Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Y.S.H. Interim / Quarterly Report 2024

Dec 19, 2024

52371_rns_2024-12-19_2812b67f-4ca7-4c11-b701-72985cc69923.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Stock Code: 3705

YUNGSHIN GLOBAL HOLDING CORPORATION AND SUBSIDIARIES

Consolidated Financial Statements and Independent Auditors’ Review Report

For the Nine Months Ended September 30, 2024 and 2023

Address: No. 1191, Sec. 1, Zhongshan Rd., Dajia Dist., Taichung City Tel: 02-25450185

Notice to Readers

For the convenience of readers, the independent auditors’ review report and the accompanying consolidated financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chineselanguage independent auditors’ review report and consolidated financial statements shall prevail.

1

Table of Contents

Item
1. Cover Page
2. Table of Contents
3. Independent Auditors' Review Report
4. Consolidated Balance Sheets
5. Consolidated Statements of Comprehensive Income
6. Consolidated Statements of Changes in Equity
7. Consolidated Statements of Cash Flows
8. Notes to Consolidated Financial Statements
1.
General Information
2.
Approval of Financial Statements
3.
Application of New and Amended Standards and Interpretations

4.
Summary of Significant Accounting Policies

5.
Critical Accounting Judgments and Key Sources of Estimation Uncertainty
and Assumptions
6.
Descriptions of Material Accounting Items

7.
Related Parties Transactions

8.
Pledged Assets
9.
Significant Contingent Liabilities and Unrecognized Contract Commitments
10. Losses due to Major Disasters
11. Significant Subsequent Events
12. Others
13. Separately Disclosed Items
(1) Information on Significant Transactions

(2) Information on Investees Companies
(3) Information on Investments in Mainland China
(4) Information of Major Shareholders
14. Segment Information
Page
1
2
34
5
6
7
8
9
9
9
911
1114
14
1544
4547
48
48
48
48
49
50
5052
53
54
54
55

2

Independent Auditors' Review Report

To the Board of Directors of YungShin Global Holding Corporation:

Introduction

We have reviewed the consolidated financial statements of YungShin Group, which comprise the Consolidated Balance Sheet as of September 30, 2024, and September 30, 2023 and the consolidated statements of comprehensive income from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023, consolidated statements of changes in equity, and consolidated statements of cash flows, and notes to the consolidated financial statements, including a summary of significant accounting policies as of period from January 1 to September 30, 2024 and 2023. Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34 “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China. Our responsibility is to express a conclusion on the consolidated financial statements based on our reviews.

Scope of Review

Except as explained in the following paragraph, we conducted our reviews in accordance with Standards on Review Engagements of the Republic of China 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity.” A review of consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Therefore, we do not express an audit opinion.

Basis for Qualified Conclusion

As disclosed in Note 4(2) of the consolidated financial statements, some non-significant subsidiaries included in the consolidated financial statements are based on the financial reports of these investee companies, which have not been reviewed by auditors for the same period. As of September 30, 2024, and September 30, 2023, the total assets of these subsidiaries amounted to NT$1,846,088 thousand and NT$1,705,901 thousand, respectively, representing 13.72% and 14.86% of the consolidated total assets. The total liabilities were NT$554,950 thousand and NT$621,137 thousand, respectively, representing 13.83% and 16.63% of the consolidated total liabilities. For the periods from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023, the comprehensive income was NT$144,420 thousand, NT$83,079 thousand, NT$327,245 thousand and NT$45,838 thousand, respectively, representing 45.85%, 27.73%, 32.01% and 7.07% of the consolidated comprehensive income.

3

In addition to the aforementioned, as stated in Note 6(7) of the consolidated financial statements, YungShin Group’s investments accounted for using the equity method amounted to NT$1,058,211 thousand and NT$1,093,716 thousand as of September 30, 2024 and 2023, respectively. The share of profit or loss from equity-method investments for the periods from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023, amounted to NT$35,730 thousand, NT$19,242 thousand, NT$88,776 thousand and NT$84,579 thousand, respectively. These amounts are based on the financial reports of the investee companies for the same period, which have not been reviewed by auditors.

Qualified Conclusion

Based on our review, except for the potential adjustments to the consolidated financial statements that might arise if the financial reports of the aforementioned investee companies had been reviewed by auditors, as described in the basis for Qualified Conclusion paragraph, we did not discover matters which would lead us to believe that the consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of YungShin Group as of September 30, 2024 and 2023, as well as its consolidated financial performance for the periods from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 and consolidated cash flows for the periods from January 1 to September 30, 2024, in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting,” endorsed and issued into effect by the Financial Supervisory Commission.

KPMG Taiwan

CPA : Min-Ju Chao Lily Lu Competent Securities : Financial-Supervisory-Securities-Auditing Authority's Approval No.1050036075 Document No. Financial-Supervisory-Securities-Sixth No.0940100754

November 5, 2024

4

YUNGSHIN GLOBAL HOLDING CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS

September 30, 2024, December 31, 2023, and September 30, 2023

Unit: In Thousands of New Taiwan Dollars

ASSETS
11xx
CURRENT ASSETS:
1100
Cash and cash equivalents (Note 6(1))
1110
Financial assets at fair value through profit or loss -
current (Note 6(2))
1136
Financial assets at amortized cost - current (Note
6(4))
1150
Notes receivable, net (Note 6(5) and (22))
1170
Accounts receivable, net (Note 6(5) and (22))
1180
Accounts receivable from related parties (Notes 6(5),
(22) and 7)
1200
Other receivables (Note 7)
1220
Current tax assets
130x
Inventories (Note 6(6))
1410
Prepayments
1470
Other current assets
Total current assets
15xx
NON-CURRENT ASSETS:
1510
Financial assets at fair value through profit or loss -
non-current (Note 6(2))
1517
Financial assets at fair value through other
comprehensive income - non-current (Note 6(3))
1550
Investments accounted for using the equity method
(Note 6(7) and (9))
1600
Property, plant and equipment (Notes 6(10), (14), (15)
and 8)
1755
Right-of-use assets (Note 6(11))
1760
Investment properties, net (Note 6(12))
1780
Intangible assets (Note 6(9) and (13))
1840
Deferred tax assets
1900
Other non-current assets (Notes 6(5), (10), (13), (22)
and 8)
Total non-current assets
1xxx
TOTAL ASSETS
9.30.2024
Amount
%
$ 1,673,607
13
63,482
-
317,058
3
249,590
2
1,343,666
10
56,617
-
26,607
-
221
-
3,130,067
23
205,804
2
10,971
-
7,077,690
53
42,000
-
187,035
2
1,058,211
8
4,592,930
34
51,711
-
30,583
-
39,355
-
137,583
1
240,667
2
6,380,075
47
$
13,457,765 100
12.31.2023 12.31.2023 9.30.2023
Amount
%

1,433,501
12

63,482
1

266,282
2

305,556
3

1,215,933
11

46,650
-

30,841
-

163
-

2,784,838
24

206,270
2

13,169
-

6,366,685
55
24,000
-
61,949
1
1,093,716
10
3,583,813
31

31,177
-

31,682
-

10,734
-

165,771
2
107,409
1

5,110,251
45
11,476,936 100
9.30.2024
LIABILITIES AND EQUITY
Amount
%
21xx
CURRENT LIABILITIES:
2100
Short-term borrowings (Notes 6(10), (14) and 8)
871,120
7
2130
Contract liabilities - current (Note 6(22))
2,777
-
2150
Notes payable
8,100
-
2170
Accounts payable
629,654
5
2181
Accounts payable to related parties (Note 7)
6,702
-
2200
Other payables (Note 7)
786,327
6
2230
Current tax liabilities
163,170
1
2280
Lease liabilities - Current (Note 6(16) and 7)
16,298
-
2322
Long-term borrowings due within one year (Note
6(10), (15) and 8)
96,893
1
2365
Refund liabilities - current (Note 6(22))
23,332
-
2399
Other current liabilities
20,456
-
Total current liabilities
2,624,829
20
25xx
NON-CURRENT LIABILITIES:
2527
Contract liabilities - non-current (Note 6(22))
359,482
3
2540
Long-term borrowings (Notes 6(10), (15) and 8)
413,214
3
2550
Provision of employee benefits - non-current
37,548
-
2570
Deferred tax liabilities
467,981
3
2580
Lease liabilities -non-current (Note 6(16) and 7)
24,356
-
2640
Net defined benefit liabilitiesnon-current
5,064
-
2675
Refund liabilities - non-current (Note 6(22))
75,557
1
2670
Other non-current liabilities
5,144
-
Total non-current liabilities
1,388,346
10
2xxx
Total liabilities
4,013,175
30
31xx
EQUITY ATTRIBUTABLE TO
OWNERS OF THE CORPORATION
(Notes 6(7), (8), (19) and (20)):
3110
Share capital
2,664,230
20
3200
Capital surplus
2,336,821
17
Retained earnings:
3310
Legal reserve
965,266
7
3320
Special reserve
350,043
3
3350
Unappropriated earnings
1,582,035
12
Total retained earnings
2,897,344
22
3400
Other equity
(230,716)
(2)
3500
Treasury shares
(1,439)
-
Total equity attributed to the owners of the
corporation
7,666,240
57
36xx
Non-controlling Interests (Note 6(8))
1,778,350
13
3xxx
Total Equity
9,444,590
70
2-3xxx
TOTAL LIABILITIES AND EQUITY
13,457,765 100
12.31.2023
Amount
%

977,411
9
239
-
1,514
-

545,488
5
11,757
-

709,102
6

121,241
1
8,545
-

1,551
-
31,567
-
19,505
-

2,427,920
21

359,482
3

241,996
2
64,116
1

391,534
3
8,408
-
28,188
-

75,557
1
270
-

1,169,551
10

3,597,471
31

2,664,230
23

2,339,474
20

881,899
8

312,829
3

1,495,724
13

2,690,452
24
(350,043)
(3)
(1,439)
-
7,342,674
64

572,289
5

7,914,963
69

11,512,434 100
9.30.2023 9.30.2023
Amount Amount % Amount Amount

977,411
239
1,514

545,488
11,757

709,102

121,241
8,545

1,551
31,567
19,505

2,427,920

359,482

241,996
64,116

391,534
8,408
28,188

75,557
270

1,169,551

3,597,471

2,664,230

2,339,474

881,899

312,829

1,495,724

2,690,452
(350,043)
(1,439)
7,342,674

572,289

7,914,963

11,512,434
Amount

1,110,867

8,726

5,243

556,877

22,370

642,080

91,389

9,714

1,938

23,679

18,616

2,491,499

350,933

242,380

62,542

392,152

9,033

43,350

142,772

280

1,243,442

3,734,941

2,664,230

2,354,803

881,899

312,829

1,280,188

2,474,916
(324,338)

(1,439)

7,168,172

573,823

7,741,995
11,476,936
%
$ 1,673,607
63,482
317,058
249,590
1,343,666
56,617
26,607
221
3,130,067
205,804
10,971

1,486,926

63,482

257,646

316,890

1,315,362

51,004

26,392

-

2,773,031

146,105

5,090

13

1

2

3

11

1

-

-

24

1

-

1,433,501

63,482

266,282

305,556

1,215,933

46,650

30,841

163

2,784,838

206,270

13,169
10
-
-
5
-
6
1
-
-
-
-
22
3
2
1
3
-
-
1
-
7,077,690
6,441,928

56

6,366,685
42,000
187,035
1,058,211
4,592,930
51,711
30,583
39,355
137,583
240,667
42,000
66,069
1,088,916
3,537,720

28,675

30,782

8,547

157,718
110,079

-

1

10

31

-

-

-

1

1
24,000
61,949
1,093,716
3,583,813

31,177

31,682

10,734

165,771
107,409
10
32
23
21
8
3
11
6,380,075
5,070,506

44

5,110,251
22
(3)
-
63
5
68
$
13,457,765
11,512,434 100 11,476,936 100

(Please refer to the accompanying notes to the consolidated financial statements for details)

Chairman: Fang-Hsin Lee

President: Chih-Wei Chien

Accounting Manager: Yu-Yi Lee

5

YUNGSHIN GLOBAL HOLDING CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

July 1 to September 30, 2024 and 2023, and January 1 to September 30, 2024 and 2023

Unit: In Thousands of New Taiwan Dollars

4000
Operating revenue (Notes 6(22) and 7)
5000
Operating costs (Notes 6(6), (10), (13), (16), (17), 7
and 12)
5900
Gross profit
6000
Operating expenses (Note 6(5), (10), (13), (16), (17),
(23), 7 and 12)
6100
Selling and marketing expenses
6200
General and administrative expenses
6300
Research and development expenses
6450
Expected credit gain on reversal
Total operating expenses
6900
Income from operations
7000
Non-operating income and expenses (Note 6(7), (9),
(10), (16), (24) and 7):
7100
Interest income
7010
Other income
7020
Other gains and losses
7050
Finance costs
7060
Share of profit or loss of associates accounted for using
the equity method
Total non-operating income and expenses
Profit before income tax of continuing operations
7950
Less: Tax expenses (Note 6(18))
Net profit for the period
8300
Other comprehensive income (Note 6(7), (8) and (18)):
8310
Items that will not be reclassified subsequently to
profit or loss
8311
Remeasurement of defined benefit obligation
8316
Unrealized gain/(loss) on investments in equity
instruments at fair value through other
comprehensive income
8320
Share of other comprehensive income of associates
accounted for using the equity method
8349
Less: Income tax relating to items that will not be
reclassified to profit or loss
Total items that will not be reclassified
subsequently to profit or loss
8360
Items that may be reclassified subsequently to
profit or loss
8361
Exchange differences on translating foreign
operations
8370
Share of other comprehensive income of associates
accounted for using the equity method
8399
Less: Income tax relating to items that may be
reclassified to profit or loss
Total items that may be reclassified
subsequently to profit or loss
8300
Other comprehensive income (loss) for the period
8500
Total comprehensive income for the period
Net profit for the period attributable to:
8610
Owners of the Corporation
8620
Non-controlling interests
Total comprehensive income attributable to:
8710
Owners of the Corporation
8720
Non-controlling interests
Earnings per share (Note 6(21))
9710
Basic earnings per share (Unit: New Taiwan Dollars)
9810
Diluted earnings per share (Unit: New Taiwan Dollars)
July to
September,

2024
%

100
56

44

17

6

5

-

28

16

1

1

(1)

(1)
2

2

18

6

12

-
(1)
-
-
(1)
1
4
1
4

3

15

10

2

12

14

1

15
0.82
0.82
July to
September,

2023
%

100
57

43

19

7

5

-

31

12

1

4

3

(1)
1

8

20

5

15

-
(1)
-
-
(1)
2
2
1
3

2

17

14

1

15

15

2

17
0.91
0.91
January to
September, 2024
Amount
%

5,876,228
100
3,281,795
56
2,594,433
44
944,089
16
394,202
7
287,373
5
(1,754)
-
1,623,910
28
970,523
16
39,557
1
26,073
-
145,892
3
(22,406)
-
88,776
1
277,892
5
1,248,415
21
338,642
6
909,773
15
(2,135)
-
(3,801)
-
-
-
-
-
(5,936)
-
25,073
-
122,262
2
28,971
-
118,364
2
112,428
2
1,022,201
17
820,109
14
89,664
1
909,773
15
938,992
16
83,209
1
1,022,201
17
3.08
3.08
January to
September, 2023
January to
September, 2023
Amount
$ 2,103,773
1,180,081
923,692
341,331
134,023
106,123
(120)
581,357
342,335
11,096
11,684
(22,319)
(8,254)
35,730
27,937
370,272
115,944
254,328
(76)
(29,522)
-
-
(29,598)
22,168
91,450
23,336
90,282
60,684
$
315,012
$ 218,468
35,860
$
254,328
$ 297,575
17,437
$
315,012
$
Amount

1,720,417
974,106
746,311
322,896
123,628
91,789
(165)
538,148
208,163
13,627
66,393
46,998
(8,923)
19,242
137,337
345,500
79,691
265,809
-
(11,075)
5,737
-
(5,338)
20,930
27,134
8,888
39,176
33,838
299,647
241,931
23,878
265,809
272,145
27,502
**299,647 **
Amount

5,876,228
3,281,795
2,594,433
944,089
394,202
287,373
(1,754)
1,623,910
970,523
39,557
26,073
145,892
(22,406)
88,776
277,892
1,248,415
338,642
909,773
(2,135)
(3,801)
-
-
(5,936)
25,073
122,262
28,971
118,364
112,428
1,022,201
820,109
89,664
909,773
938,992
83,209
1,022,201
Amount

5,083,572
2,908,244

2,175,328

900,994

355,877

272,294

(884)

1,528,281

647,047

37,748

76,219

52,118

(26,266)
84,579

224,398

871,445

216,447

654,998

-
10,619
3,226
-
13,845
(1,513)
(25,426)
(6,339)
(20,600)

(6,755)

648,243

618,133

36,865

654,998

606,624

41,619

648,243
%
100
57
43
18
7
5
-
30
13
1
2
1
(1)
1
4
17
4
13
-
-
-
-
-
-
-
-
-
-
13
12
1
13
12
1
13
2.32
$ 2.32

(Please refer to the accompanying notes to the consolidated financial statements for details) Chairman: Fang-Hsin Lee President: Chih-Wei Chien Accounting Manager: Yu-Yi Lee

Accounting Manager: Yu-Yi Lee

6

YUNGSHIN GLOBAL HOLDING CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

January 1 to September 30, 2024 and 2023

Unit: In Thousands of New Taiwan Dollars

Equity Attributed to the Owners of the Corporation

Balance on January 1, 2023
Appropriation of earnings:
Recognition of Legal reserve
Reversal of Special reserve
Cash dividends on ordinary shares
Net profit for the period
Other comprehensive income (loss) for the
period
Total comprehensive income for the period
Changes in capital surplus from investments
in associates accounted for using the
equity method
Adjustment to capital surplus from dividends
paid to subsidiaries
Changes in ownership interests in
subsidiaries
Cash dividends of non-controlling interests
Balance on September 30, 2023
Balance on January 1, 2024
Appropriation of earnings:
Recognition of Legal reserve
Recognition of Special reserve
Cash dividends on ordinary shares
Net profit for the period
Other comprehensive income (loss) for the
period
Total comprehensive income for the period
Adjustment to capital surplus from dividends
paid to subsidiaries
Changes in ownership interests in
subsidiaries
Cash dividends of non-controlling interests
Changes in non-controlling interests
Balance on September 30, 2024
Share
Capital
Capital
Surplus
Retained Earnings Retained Earnings Other Equity Items Treasury
Shares
Total Equity
Attributed to
the Owners of
the
Corporation
Non-
Controlling
Interests
Total
Equity
Exchange
Differences
on
Translating
Foreign
Operations
Unrealized Gain
(Loss) on
Financial Assets
at Fair Value
Through Other
Comprehensive
Income
Total
Legal
Reserve
Special
Reserve
Unappropriated
Earnings
Total
$ 2,664,230
-
-
-
-
-
2,340,374
-
-
-
-
-

800,994

80,905

-

-

-

-
391,162
-
(78,333)
-
-
-
1,277,400
(80,905)
78,333
(612,773)
618,133
-

2,469,556

-

-

(612,773)

618,133

-

(336,084)

-

-

-

-
(25,354)
23,255
-
-
-
-
13,845
(312,829)

-

-

-

-

(11,509)
(1,439)
-
-
-
-
-
7,159,892
-
-
(612,773)
618,133
(11,509)

543,259

-

-

-

36,865
4,754
7,703,151
-
-
(612,773)
654,998
(6,755)

-
-
-
- 618,133
618,133

(25,354)
13,845
(11,509)
- 606,624
41,619
648,243
-
-
-

-
(1,353)
98
15,684
-

-

-

-

-
-
-
-
-
-
-
-
-

-

-

-

-
-
-
-

-
-
-
-
-

-

-

-

-
-
-
-
-
(1,353)
98
15,684
-

-

-

25,514

(36,569)
(1,353)
98
41,198
(36,569)
$ 2,664,230 2,354,803 881,899 312,829 1,280,188 **2,474,916 **
(361,438)
37,100 (324,338) (1,439) 7,168,172 573,823 7,741,995
$ 2,664,230
-
-
-
-
-
2,339,474
-
-
-
-
-

881,899

83,367

-

-

-

-
312,829
-
37,214
-
-
-
1,495,724
(83,367)
(37,214)
(612,773)
820,109
(444)

2,690,452

-

-

(612,773)

820,109
(444)

(386,296)

-

-

-

-
115,884
36,253
-
-
-
-
3,443

(350,043)

-

-

-

-

119,327
(1,439)
-
-
-
-
-
7,342,674
-
-
(612,773)
820,109
118,883

572,289

-

-

-

89,664

(6,455)
7,914,963
-
-
(612,773)
909,773
112,428

-
-
-
- 819,665
819,665

115,884
3,443
119,327
- 938,992
83,209
1,022,201
-
-

-
-
98
(2,751)
-
-

-

-

-

-
-
-
-
-
-
-
-
-

-

-

-

-
-
-

-

-
-
-
-
-

-

-

-

-
-
-
-
-
98
(2,751)
-
-

-

(1,205)

(58,225)

1,182,282
98
(3,956)
(58,225)
1,182,282
$ 2,664,230 2,336,821 965,266 350,043 1,582,035 **2,897,344 **
(270,412)
39,696 (230,716) (1,439) 7,666,240 1,778,350 9,444,590

(Please refer to the accompanying notes to the consolidated financial statements for details)

Chairman: Fang-Hsin Lee

President: Chih-Wei Chien

Accounting Manager: Yu-Yi Lee

7

YUNGSHIN GLOBAL HOLDING CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS

January 1 to September 30, 2024 and 2023

Unit: In Thousands of New Taiwan Dollars

CASH FLOWS FROM OPERATING ACTIVITIES:
Profit before income tax
Adjustments for:
Profit and loss items
Depreciation
Amortization
Expected credit gain on reversal
Interest expenses
Interest income
Dividend income
Share of profit or loss of associates accounted for using the equity method
Gain (loss) on disposal of property, plant and equipment
Property, plant and equipment transferred to expenses
Gain on re-measurement of investment
Gains on lease modifications
Total profit and loss items
Changes in operating assets/liabilities:
Net changes in operating assets:
Notes receivable
Accounts receivable
Accounts receivable from related parties
Other receivables
Inventories
Prepayments
Other current assets
Total net changes in operating assets
Net changes in operating liabilities:
Contract liabilities
Notes payable
Accounts payable
Accounts payable to related parties
Other payables
Provisions for liabilities
Other liabilities (included refund liabilities)
Net defined benefit liabilities
Total net changes in operating assets and liabilities
Total net changes in assets and liabilities related to operating activities
Total adjustments
Cash inflow from operations
Interest received
Dividend received
Interest paid
Income tax paid
Net cash inflow from operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of financial assets at fair value through other comprehensive income
Acquisition of financial assets at amortized cost
Acquisition of property, plant and equipment
Proceeds from disposal of property, plant and equipment
Increase in refundable deposits
Purchase of intangible assets
Cash inflow from business combination
Increase in other non-current assets
Increase in prepayments for equipment
Dividend received
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in short-term borrowings
Decrease in short-term borrowings
Proceeds from long-term borrowings
Repayments of long-term borrowings
Increase (decrease) in guarantee deposits received
Repayment of the principal portion of lease liabilities
Distribution of cash dividends
Disposal of equity in subsidiaries
Changes in non-controlling interests
Net cash outflow from financing activities
Effects of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Balance of cash and cash equivalents at the beginning of period
Balance of cash and cash equivalents at the end of the period
January to
September, 2024
$ 1,248,415
212,837
1,807
(1,754)
22,406
(39,557)
(4,936)
(88,776)
884
359
(113,185)
(17)
(9,932)
70,926
106,038
11,000
5,628
(208,914)
(48,646)
6,145
(57,823)
2,507
6,586
35,700
(5,055)
22,347
(26,568)
(2,865)
(25,259)
7,393
(50,430)
(60,362)
1,188,053
34,301
39,619
(23,628)
(231,759)
1,006,586
(131)
(59,412)
(140,636)
6,797
(102,220)
(600)
132,393
(15,642)
(9,727)
4,936
(184,242)
1,513,630
(1,634,787)
265,000
(127,567)
(23)
(11,835)
(670,900)
-
(3,956)
(670,438)
34,775
186,681
1,486,926
$
1,673,607
January to
September, 2023
871,445
211,009
12,321
(884)
26,266
(37,748)
(116)
(84,579)
(218)
1,159
-
-
127,210
13,017
121,799
28,761
3,503
(65,515)
(63,896)
2,173
39,842
(186)
4,566
132,092
1,340
(29,665)
4,657
(21,881)
(31,734)
59,189
99,031
226,241
1,097,686
36,081
42,045
(28,048)
(230,403)
917,361
(125)
(260,908)
(53,082)
438
(14,297)
(2,035)
-
(29,144)
(4,265)
116
(363,302)
262,440
(710,516)
110,000
(112,403)
256
(10,590)
(649,244)
39,927
1,271
(1,068,859)
(8,247)
(523,047)
1,956,548
1,433,501

(Please refer to the accompanying notes to the consolidated financial statements for details) President: Chih-Wei Chien

Chairman: Fang-Hsin Lee

Accounting Manager: Yu-Yi Lee

8

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements

For the Nine Months Ended September 30, 2024 and 2023 (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

1. General Information

YungShin Global Holding Corporation (the “Corporation”) was established in January 2011. The Corporation and its subsidiaries (collectively referred herein as the “Group”) are mainly engaged in investing, manufacturing and selling medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics.

The Corporation was incorporated on January 3, 2011, through a share swap with Yung Shin Pharmaceutical Industrial Company Limited (hereinafter referred to as “Yung Shin Pharmaceutical”, and the Corporation's shares have been traded on the Taiwan Stock Exchange in the Republic of China since January 3, 2011. Yung Shin Pharmaceutical is a wholly-owned subsidiary of the Corporation.

2. Approval of Financial Statements

The consolidated financial statements were approved for issuance by the Board of Directors on November 5, 2024.

3.

Application of New and Amended Standards and Interpretations

  • (1) Effect of adopted newly issued and amended standards and interpretations endorsed by the Financial Supervisory Commission (hereafter referred to as the “FSC”)

  • The Group has applied for the following newly amended IFRS IAS effective January 1, 2024, which has not caused any material impact on its consolidated financial statements.

  • Amendments to IAS 1 “Classification of Liabilities as Current or Non-current”

  • Amendments to IAS 1 “Non-current Liabilities with Covenants”

  • Amendments to IAS 7 and IFRS 7 “Supplier Finance Arrangements”

  • Amendments to IFRS 16 “Lease Liability in a Sale and Leaseback”

  • (2) The impact of IFRS issued by the FSC but not yet effective

The Group expects that the following amendments to IFRS issued into effect on January 1, 2025 will not have a material impact on the consolidated financial statements.

  • Amendments to IAS 21 “Lack of Exchangeability”

  • (3) New and amended standards and interpretations not yet endorsed by the FSC

The International Accounting Standards Board (IASB) has issued and amended standards and interpretations that have not yet been endorsed by the Financial Supervisory Commission (FSC), which may be relevant to the Group as follows:

9

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

Newly Issued or

Amended Standards

International Financial Reporting Standards 18 “Presentation and Disclosure in Financial Statements”

Significant Amendments

The new standards introduce three categories of income and expenses, two subtotals in the income statement, and a single note regarding management performance measures. These three amendments and enhancements to the guidelines for disaggregating information in the financial statements provide a foundation for better and more consistent information for users and will impact all companies.

Effective Date of the Standards Issued by the IASB January 1, 2027

  • More Structured Income Statement: Under the current standards, companies use different formats to present their operating results, making it difficult for investors to compare the financial performance of different companies. The new standards adopt a more structured income statement, introducing a newly defined subtotal for “operating profit.” Additionally, all income and expenses will be classified into three new distinct categories based on the company's primary operating activities.

  • Management Performance Measures (MPM): The new standards introduce a definition for management performance measures and require companies to include a single note in the financial statements explaining why each measure provides useful information, how it is calculated, and how the measure reconciles to amounts recognized according to International Financial Reporting Standards.

  • More Disaggregated Information: The new standards include guidance on how companies should enhance the grouping of information in their financial statements. This includes guidance on whether information should be included in the primary financial statements or further disaggregated in the notes.

10

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

The Group is currently assessing the impact of the aforementioned standards and interpretations on its financial position and operating results. The related impacts will be disclosed upon completion of the assessment.

The Group anticipates that the following newly issued and amended standards to be determined will not have significant impact on the consolidated financial statements.

  • Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets between an Investor and its Associate or Joint Venture”

  • IFRS 17 “Insurance Contracts” and Amendments to IFRS 17

  • IFRS 19 “Subsidiaries without Public Accountability: Disclosures”

  • Amendments to IFRS 9 and IFRS 7 “Classification and Measurement of Financial Instruments”

  • Annual Improvements to IFRS Accounting Standards

4. Summary of Significant Accounting Policies

Except as described below, the significant accounting policies adopted in these consolidated financial statements are consistent with those applied in the 2023 annual consolidated financial statements. For related information, please refer to Note 4 of the 2023 annual consolidated financial statements.

  • (1) Statement of Compliance

These consolidated financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers (hereinafter referred to as “Regulations of Preparation”) and IAS 34 “Interim Financial Reporting” as endorsed and issued into effect by the FSC. These consolidated financial statements do not include all the necessary information required to be disclosed in a complete set of annual consolidated financial statements prepared in accordance with the IFRS, IAS, interpretations, and interpretations announcements endorsed and issued into effect by the Financial Supervisory Commission (hereinafter referred to as the “FSCendorsed IFRS”).

  • (2) Basis of Consolidation

The principles for preparing the consolidated financial statements are consistent with those applied in the 2023 annual consolidated financial statements. For related information, please refer to Note 4(3) of the 2023 annual consolidated financial statements.

11

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • 1) The subsidiaries included in the consolidated financial statements are listed as follows:
follows:
Investor
Company
Subsidiary Name
Yung Shin Pharmaceutical
Industrial Co., Ltd.
(YSP)
Chemix Inc. (Chemix)
YSP International
Company Limited
(YSP Inc)
Vetnostrum Animal
Health Co., Ltd.
Yung Zip Chemical Ind.
Co., Ltd. (Yung Zip)
Angel Associates
(Taiwan), Inc.
YZP Oversea Investment
Co., Ltd.
Taiwan Way Chein
Industrial Co., Ltd.
Carlsbad Technology ,Inc.
(CTI)
YungShin TienTe
(Shanghai)
Pharmaceutical Trading
Co., Ltd. (YST)
Yung Shin Company
Limited (YHK)
Business
Activities

Manufacturing
and sale of
medicine and
cosmetics
Sale of medicine
Trade,
investment, and
other related
businesses
Manufacturing
and sale of
medicine
Manufacture and
sale of active
pharmaceutical
ingredients
Import and export
trading
General
investments
Food
Manufacturing
Manufacturing
and sale of
medicine
Import and export
trading
Sale of medicine
Proportion of Ownership (%)
9.30.2024
100.00%
100.00%
100.00%
55.12%
20.81%
73.50%
100.00%
70.00%
74.13%
100.00%
96.50%
12.31.2023
100.00%
100.00%
100.00%
54.97%
-%
73.50%
-%
-%
74.13%
100.00%
96.50%
9.30.2023
Remark
The
Corporation
The
Corporation
The
Corporation
The
Corporation
The
Corporation
Yung Shin
Pharmaceutical
Yung Zip
Yung Zip
YSP INC
YSP INC
YSP INC
100.00%
100.00%

100.00%

54.71%

-%

73.50%

-%

-%

74.13%

100.00%

96.50%
Note 2
Note 2
Note 1
Note 4
Note 2
Notes 2
and 4
Note 4
Note 2
Notes 2
and 3
Note 2

Note 1: Vetnostrum Animal Health issued 77 thousand new shares in August 2023 due to the exercise of employee stock options. Moreover, the Group purchased 175 thousand shares of Vetnostrum Animal Health in December 2023. After the aforementioned transaction, the Group's shareholding percentage in Vetnostrum Animal Health Co., Ltd. was adjusted from 54.71% to 54.97%. The Group purchased 84 thousand shares, 17 thousand shares and 24 thousand shares of Vetnostrum Animal Health in January, February and May 2024, respectively. Vetnostrum Animal Health issued 3 thousand and 47 thousand new shares in March and August 2024 due to the exercise of employee stock options. After the aforementioned transaction, the Group's shareholding percentage in Vetnostrum Animal Health Co., Ltd. was adjusted from 54.97% to 55.12%.

  • Note 2: The Company is not a major subsidiary, its financial statements have not been reviewed by auditors.

  • Note 3: Shanghai Yung Zip Pharmaceutical Trading Co., Ltd. changed its name to YungShin TienTe (Shanghai) Pharmaceutical Trading Co., Ltd. on August 2, 2023.

  • Note 4: On May 30, 2024, Yung Zip held a by-election for one director position. After the by-election, the Group obtained more than half of the director seats, giving it control over Yung Zip and its subsidiaries.

2) Subsidiaries excluded from the consolidated financial statements: None.

(3) Employee Benefits

Defined benefit plans for an interim period are calculated based on the actuarially determined pension cost rate at the end of the immediately preceding fiscal year. The calculation basis is from the beginning of the year to the end of the period, and it is adjusted for any significant market volatility, significant reductions, settlement or other significant one-off events.

12

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(4) Income Tax

The Group measures and discloses income tax expenses for the interim period in accordance with paragraph B12 of IAS 34 “Interim Financial Reporting” endorsed by the FSC.

Income tax expense is measured at the amount by which the profit before tax during the reporting period by the management’s best estimate of the expected effective tax rate for the year, it is apportioned into current income tax expenses and deferred income tax expenses according to the estimated proportion of current income tax expenses and deferred income tax expenses for the current year.

Income tax expenses recognized directly in equity or other comprehensive income are measured as the temporary difference between the carrying amounts of the related assets and liabilities for financial reporting purposes and their tax bases, using the applicable tax rates for expected realization or settlement.

(5) Business Combinations

The acquiring company applies the acquisition method for each business combination. Goodwill is measured at the fair value of the consideration transferred at the date of acquisition, including the amount attributable to any non-controlling interest in the acquiree, less the net amount of the identifiable assets acquired, and liabilities assumed (generally the fair value). If the resulting balance is negative, the acquiring company reassesses whether all assets acquired, and liabilities assumed have been correctly identified before recognizing the gain on bargain purchase in profit or loss.

Except for those related to the issuance of debt or equity instruments, transaction costs associated with a business combination should be recognized as expenses of the combining company immediately when incurred.

For non-controlling interest in the acquiree, if they represent current ownership interest and the holder is entitled to a proportionate share of the net assets of the of the entity upon liquidation, the acquiring company chooses to measure these interest, on a transaction-bytransaction basis, either at fair value or based on proportionate share of the current ownership instrument to the recognized amount of the acquiree's identifiable net assets. Other non-controlling interests are measured at the fair values at the acquisition date or on other bases in accordance with IFRS Accounting Standards approved by the FSC.

For a business combination concluded in stages, the acquiring company should remeasure the interests of the acquiree previously held based on the fair value on the acquisition date. Any resulting gain or loss is recognized as profit or loss. Changes in the value of the acquiree's interest that were recognized in other comprehensive income before the acquisition date should be treated in the same manner as if the acquiring company had directly disposed of its previously held interest. If it is appropriate to reclassify the interest to profit or loss upon disposal, the amount is reclassified to profit or loss.

13

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

If the initial accounting treatment for a business combination is not completed before the reporting date of the combination transaction, the acquiring company recognizes provisional amounts for incomplete accounting items and makes retroactive adjustments or recognizes additional assets or liabilities during the measurement period to reflect the new information about the existing facts and conditions on the acquisition date. The measurement period will not exceed one year from the date of acquisition.

5. Critical Accounting Judgments and Key Sources of Estimation Uncertainty and Assumptions

The preparing of the consolidated financial statements in conformity with the Preparation Regulations and IAS 34 “Interim Financial Reporting” endorsed by the FSC requires management to make judgments, estimates and assumptions, which may affect the adoption of accounting policies, and the reporting amount of assets, liabilities, incomes and expenses. Actual results may differ from original estimates.

In preparing the consolidated financial statements, the significant judgments made by management in applying the Group's accounting policies and the key sources of estimation uncertainty are consistent with those disclosed in Note 5 of the 2023 annual consolidated financial statements.

Accounting policies involve significant judgments, and information that has a significant impact on the amounts recognized in the financial statements of the Group is as follows:

  • (1) The Group holds 36.92% of the voting rights of YSP SAH and is the single largest shareholder. The remaining holdings are not concentrated in specific shareholders; however, the Group is unable to obtain more than half of the Board of Directors of YSP SAH. Therefore, the Group are unable to dominate the activities of YSP SAH and does not have control over the company. The Group's management believes that it has significant influence over YSP SAH, and thus classifies it as an associate of the Group.

  • (2) The Group holds 20.81% of the voting rights in Yung Zip, and is the single largest shareholder and treated as an associates for using the equity method. However, following the board of directors' by-election on May 30, 2024, the Group obtained a majority of the board seats in Yung Zip. Consequently, the Group gained control over Yung Zip from May 30, 2024 onwards and began to apply accounting policies related to business combinations.

14

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

6. Descriptions of Material Accounting Items

Except as described below, explanations of important accounting items in these consolidated financial statements are not significantly different from those in the 2023 consolidated financial statements. For related information, please refer to Note 6 of the 2023 consolidated financial statements.

  • (1) Cash and Cash Equivalents
Cash and Cash Equivalents
Cash on hand
Demand deposits and check
deposits
Time deposits
9.30.2024
$ 1,425
1,672,182
-
$
1,673,607
12.31.2023
820
1,482,106
4,000
1,486,926
9.30.2023

861

1,428,640

4,000

1,433,501

Please refer to Note 6(25) for disclosure on the interest rate risk and sensitivity analysis.

  • (2) Financial Assets at Fair Value Through Profit or Loss - Current and Non-Current
Financial assets mandatorily
at FVTPL
Product development
investment agreements
Private equity funds
Total
9.30.2024
$ 63,482
42,000
$
105,482
12.31.2023
63,482
42,000
105,482
9.30.2023

63,482
24,000

87,482

The Group and other companies signed an investment agreement for product development cooperation. The agreement stipulates that when the product development results are authorized and the authorization fee is obtained, the royalties will be distributed in a certain proportion.

Please refer to Note 6(25) for market risk information.

15

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(3) Financial Assets at Fair Value Through Other Comprehensive Income - Non-Current

Equity instruments measured
at fair value through other
comprehensive income:
Listed shares:
Sawai Pharmaceutical
Co., Ltd.
ANA Holding Inc.
Unlisted shares:
Missioncare Co., Ltd.
Missioncare Asset
Management Co., Ltd.
Limited Liability
Fengyuan Medical
Waste Disposal
Equipment Used
Cooperatives
International Green
Handle Co., Ltd.
LTC Holding Company
Ltd.
Total
9.30.2024
$ 7,970
682
8,652
62,592
31,637
11
20
84,123
178,383
$
187,035
12.31.2023 9.30.2023

6,532

664
5,634

677

7,196

6,311

44,466

14,387

7

13
-

42,736
12,884
6
12
-

58,873

55,638

66,069

61,949

Equity instruments held by the Group are strategic long-term investments, instead of trading purpose. Therefore, they have been designated to be measured at fair value through other comprehensive income.

The Group did not have any disposal of strategic investments in the nine months ended September 30, 2024 and 2023, and there were no transfers of accumulated gains and losses within equity during this period.

Please refer to Note 6(25) for market risk information.

(4) Financial Assets at Amortized Cost - Current

Time deposits with original
maturities of more than 3
months

Interest Rate Range (%)
9.30.2024 12.31.2023
257,646
1.45~5.57
9.30.2023
266,282
1.45~5.15
$
317,058
1.25~5.48

The Group assesses that the asset is held to maturity to receive contractual cash flows. The asset is classified as financial assets at amortized cost because the cash flows from the financial asset are solely the payment of principal and interest on the outstanding principal amount.

16

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(5) Notes Receivable and Accounts Receivable

Notes receivable
Accounts receivable
Accounts receivable from related
parties
Overdue receivable (classified as
other non-current assets)
Less: Loss allowance - notes
receivable
Loss allowance - accounts
receivable
Loss allowance - overdue
receivable (classified as
other non-current assets)
9.30.2024 12.31.2023 9.30.2023
$ 249,821
1,348,539
56,617
-
(231)
(4,873)
-

317,520

1,321,397
51,004
70
(630)
(6,035)
(70)
306,175
1,222,293
46,650
-
(619)
(6,360)
-
$
**1,649,873 **

1,683,256
1,568,139

None of the Group's notes receivable and accounts receivable are discounted or provided as collaterals.

The Group adopts a simplified method to estimate the expected credit loss for all notes receivable and accounts receivable (including related parties), that is, using the lifetime expected credit loss. For this purpose, these notes receivable and accounts receivables are categorized based on common credit risk characteristics of customers' capability to pay for amount due in accordance with the contracts with forward-looking information incorporated, including general economic and related industry information. Due to the historical experience of credit losses of the Group, there is no significant difference in the loss patterns of different client groups. Therefore, the provision matrix does not further distinguish the customer base.

The expected credit loss analysis of the Group's notes receivable and accounts receivable was as follows:

Not past due
1 ~ 30 days past due
31 ~ 60 days past due
61 ~ 90 days past due
91 ~ 120 days past due
121 ~ 180 days past due
181 ~ 270 days past due
Over 365 days past due
9.30.2024
Carrying Amount
of Notes Receivable
and Accounts
Receivable
$ 1,496,116
122,404
31,096
2,365
82
1,574
366
974
$
**1,654,977 **
Weighted
Average
Expected Credit
Loss Rate (%)

0.26

0.13

0.02

0.13

-

-

-

100.00
Allowance for
Expected Credit
Losses During
the Period
3,960
161
6
3
-
-
-
974
**5,104 **

17

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

Not past due
1 ~ 30 days past due
31 ~ 60 days past due
61 ~ 90 days past due
91 ~ 120 days past due
121 ~ 180 days past due
181 ~ 270 days past due
Over 365 days past due
12.31.2023
Carrying Amount
of Notes Receivable
and Accounts
Receivable
$ 1,381,433
193,251
29,017
22,724
24,326
39,139
31
$
1,689,921
Weighted
Average
Expected Credit
Loss Rate(%)

0.41

0.37

0.65

0.42

0.16

0.01

12.90
Allowance for
Expected Credit
Losses During
the Period
5,617
717
190
95
39
3
4
6,665

The above accounts receivable amount does not include NT$70 thousand owed by a single sales customer to the Group. Due to the unstable assessment of the receivables' collectability from this customer, a full provision for loss has been made against the aforementioned amount, and therefore, it is not included in the calculation of the Group's expected credit losses for the remaining period.

Not past due
1 ~ 30 days past due
31 ~ 60 days past due
61 ~ 90 days past due
91 ~ 120 days past due
121 ~ 180 days past due
181 ~ 270 days past due
271 ~ 365 days past due
Over 365 days past due
9.30.2023
Carrying Amount
of Notes Receivable
and Accounts
Receivable
Weighted
Average
Expected Credit
Loss Rate (%)
Allowance for
Expected Credit
Losses During
the Period
$ 1,280,559
102,931
42,060
48,445
50,454
46,927
749
99
2,894
0.30
0.13
0.03
0.01
0.01
-
-
87.88
100.00
3,851
129
13
2
3
-
-
87
2,894
$
1,575,118
6,979

Changes in allowance for loss on notes receivable and accounts receivable of the Group are as follows:

Balance on January 1
Recognized impairment gain on reversal
Amounts written off as uncollectible during
the year
Acquired by combinations
Difference of foreign exchange
Balance at end of period
January to
September, 2024
$ 6,735
(1,754)
-
97
26
$
5,104
January to
September, 2023
7,785
(884)
(36)
-
114
6,979

18

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(6) Inventories

Finished goods
Work in process (include
semi-finished products)
Raw materials
Supplies
Inventory in transit
9.30.2024
$ 1,427,107
307,873
1,190,382
194,705
10,000
$
3,130,067
12.31.2023 9.30.2023
973,271
295,035
1,299,045
181,459
24,221

1,220,510

239,601

968,518

172,711

183,498
2,773,031
2,784,838

The Group transferred the inventory from normal sales to operating costs. In addition, it includes other expenses and losses directly in operating costs as follows:

Inventory write-down and
obsolescence loss (gain on
reversal)
Loss for inventory
obsolescence
Gain on physical inventories
Revenue from sale of scraps
Total
July to
September, 2024

July to
September, 2023

January to
September, 2024

January to
September, 2023
$ (2,682)
19,856
(529)
(49)

(7,042)

10,941

(419)
(62)

(6,219)

51,420

(1,235)
(171)

792

39,089

(1,212)
(214)
$
16,596

3,418

43,795

38,455

The Group did not pledge any inventories as collateral.

  • (7) Investments Accounted for Using Equity Method

Investments of the Group under equity method at reporting date are listed as below:

Associate 9.30.2024
$
1,058,211
12.31.2023
1,088,916
9.30.2023
1,093,716

1) Associate

Relevant information on the associates that are material to the Group is as follows:

Name of
Associate
Nature of
Relationship with
the Group
Principal Place of
Business/Country
of Registration
Proportion of Ownership
and Voting Rights
Proportion of Ownership
and Voting Rights
Proportion of Ownership
and Voting Rights
9.30.2024 **12.31.2023 ** 9.30.2023
YSP SAH Biopharmaceutical
research and
technical services

Malaysia
36.92% 36.92% 36.94%

The fair values of the associates as listed companies that are material to the Group were as follows:

were as follows:
YSP SAH 9.30.2024
$
965,567
12.31.2023
806,689
9.30.2023
864,705

19

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

Summary financial information on the associates that are material to the Group was as follows:

as follows:
9.30.2024 12.31.2023
9.30.2023
Current assets $ 2,687,278 2,368,749 2,406,169
Non-current assets 1,306,499 1,119,063 1,158,357
Current liabilities (483,239) (458,688) (507,125)
Non-current liabilities (377,721) (341,789) (361,988)
Net assets $ 3,132,817 2,687,335 2,695,413
Net assets attributable
to non-controlling
interests $ 50,666 41,316 41,842
Net assets attributable
the owners of
investee $ 3,082,151 2,646,019 2,653,571
July to July to January to
January to
September, September,
September,
September,
2024 2023 2024 2023
Operating revenue $ 634,980 619,386
1,882,002

1,820,824
Net profit of continuing
operations for the period $ 97,322 40,900
212,273

200,451
Other comprehensive
income 247,716 73,382
331,177

(68,826)
Total comprehensive
income $ **345,038 ** 114,282
543,450

131,625
January to
January to
September, 2024
September, 2023
The Group's shares of associates' net
assets at the beginning of the period $ 976,844 967,957
Total comprehensive income attributable
to the Group for the period 200,628 48,668
Cash dividends from associates (39,619) (34,991)
The Group's share of associates' net
assets at the end of the period 1,137,853 981,634
Less: Capital surplus - (1,353)
The Group's carrying amount of the
associates interest at the end of the
period $
1,137,853
980,281

2) Guarantee

As of September 30, 2024, December 31, 2023 and September 30, 2023, the investments accounted for using the equity method by the Group were not pledged as collateral.

3) Investments accounted for using equity method has not reviewed by auditors

Investments accounted for using the equity method and the share of profit or loss and other comprehensive income of those investments were calculated based on financial statements which have not been reviewed by CPAs.

20

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(8) Subsidiaries with Significant Non-Controlling Interests

The non-controlling interests of subsidiaries that are significant to the Group are as follows:

1) Vetnostrum Animal Health Co., Ltd.

Subsidiary Name
Vetnostrum Animal
Health Co., Ltd
Principal Place of
Business/Country of
Registration
Taiwan
Proportion of Non-Controlling Interests in
Ownership Interests and Voting Rights
Proportion of Non-Controlling Interests in
Ownership Interests and Voting Rights
Proportion of Non-Controlling Interests in
Ownership Interests and Voting Rights
9.30.2024

44.88%
12.31.2023 9.30.2023
45.03% 45.29%

The summary financial information of the above subsidiaries is stated as follows, prepared in accordance with IFRS endorsed by the FSC and reflecting adjustments made by the Group to the fair value and differences in accounting policies on the acquisition date, with the amount before elimination of the transactions between the Group, is as follows:

Current assets
Non-current assets
Current liabilities
Non-current liabilities
Net assets
Net assets attributable to
non-controlling interests
9.30.2024
$ 716,165
1,088,974
(291,163)
(114,082)
$
1,399,894
$
491,265
12.31.2023
677,904
1,102,059
(310,324)
(103,099)
1,366,540
478,223
9.30.2023
665,242
1,111,615
(329,102)
(103,148)
1,344,607
471,216
Operating revenue
Net profit for the period
Other comprehensive income
for the period
Total comprehensive income
for the period
Net profit for the period
attributable to non-
controlling interests
Total comprehensive income
attributable to non-
controlling interests
July to
September,
2024
$
360,777
$ 42,350
-
$
42,350
$
18,881
$
18,881
July to
September,
2023
324,436
28,106
-
28,106
12,601
12,601
January to
September,
2024
January to
September,
2023

968,583
914,853

101,472
-
70,201
-
101,472 70,201
45,165 30,905
45,165 30,905
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Net increase (decrease) in cash and cash
equivalents
January to
September, 2024
$ 181,116
(22,746)
(114,547)
$
43,823
January to
September, 2023
194,176
(9,936)
(185,277)
(1,037)

21

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

The Group purchased 84 thousand shares, 17 thousand shares and 24 thousand shares of Vetnostrum Animal Health in January, February and May 2024, respectively, for a total purchase price of NT$4,781 thousand. Additionally, Vetnostrum Animal Health issued 3 thousand and 47 thousand new shares in March and August 2024, respectively to employees exercising stock options, at an issuance price of NT$825 thousand. The aforementioned transactions resulted in a decrease in capital surplus of NT$2,751 thousand, and the ownership percentage increased from 54.97% to 55.12%.

2) Yung Zip

Subsidiary Name
Yung Zip

Principal Place of
Business/Country of
Registration
Taiwan
Proportion of Non-Controlling Interests in
Ownership Interests and Voting Rights
Proportion of Non-Controlling Interests in
Ownership Interests and Voting Rights
Proportion of Non-Controlling Interests in
Ownership Interests and Voting Rights
9.30.2024

79.19%
12.31.2023
(Note)
9.30.2023
(Note)

Note: On May 30, 2024, Yung Zip held a by-election for one director position. After the by-election, the Group obtained more than half of the director seats, giving it control over Yung Zip, which was included in the consolidated entity from the date of obtaining control.

The summary financial information of the above subsidiaries is stated as follows, prepared in accordance with IFRS endorsed by the FSC and reflecting adjustments made by the Group to the fair value and differences in accounting policies on the acquisition date, with the amount before elimination of the transactions between the Group, is as follows:

Current assets
Non-current assets
Current liabilities
Non-current liabilities
Net assets
Net assets attributable to non-controlling interests
Operating revenue
Net profit for the period
Other comprehensive income (loss) for the period
Total comprehensive income for the period
Net profit for the period attributable to non-controlling interests
Total comprehensive income attributable to non-controlling interests
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Net decrease in cash and cash equivalents
9.30.2024
$ 411,971
1,252,781
(117,915)
(106,593)
$
1,440,244
$
1,163,309
June to
September, 2024
$ 197,234
$ 21,788
(9,150)
$ 12,638
$ 17,701
$ 10,455
June to
September, 2024
$ 28,081
(11,871)
(50,833)
$
(34,623)

22

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • (9) Business Combinations - Acquisition of Subsidiary, Yung Zip

  • 1) Transfer consideration for acquisition of subsidiaries

The Group acquired a cumulative 20.81% common stock equity in Yung Zip in May 2024. On May 30, 2024, Yung Zip held a by-election for one director position. After the by-election, the Group obtained more than half of the director seats, giving it control over this company, which was included in the consolidated entity from the date of obtaining control and generate re-measurement benefits of NT$113,185 thousand.

  • 2) Details of the fair values of net identifiable assets acquired and liabilities assumed were as below:

Details of the fair values of identifiable assets acquired and liabilities assumed of Yung Zip on May 30, 2024 (the date control was obtained) were as below:

Transfer consideration
Add: fair value of the original interest in the
acquiree
Non-controlling interests (measured as the
ratio of identifiable net assets to non-
controlling interests)
Less: fair value of identifiable net assets:
Cash and cash equivalents
Notes receivable and receivable (including
related parties)
Inventories
Other current assets
Financial assets at fair value through other
comprehensive income - non-current
Property, plant and equipment
Right-of-use assets
Intangible assets
Other non-current assets
Accounts payable
Other current liabilities
long-term borrowings
Other non-current liabilities
Goodwill
$ 132,393
152,869
148,122
23,666
142,512
1,108,443
1,538
1,491
26,919
(48,466)
(91,390)
(129,136)
(21,110)
$ -
309,487
1,168,887
1,447,851
$
30,523

The fair value measurement of the assets and liabilities acquired by the Group mentioned above is provisional, and the amount is subject to final assessment.

The Group will continue to review the above matters during the measurement period. If new information related to facts and circumstances that existed on the acquisition date is obtained within one year from the acquisition date, which can identify adjustments to the aforementioned provisional amounts or any additional provisions for liabilities that existed on the acquisition date, the accounting treatment of the acquisition will be modified.

23

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • 3) Intangible assets

  • Goodwill primarily arises from its profitability, the synergy effect is the combination with Yung Zip, and the anticipated development of the future active pharmaceutical ingredients market, with an expected effect of no income tax effect.

  • 4) Pro forma information on operating results

  • As of May 30, 2024, the operating results of Yung Zip was consolidated into the Group's consolidated statements of comprehensive income, contributing a net operating revenue of NT197,234 thousand and a net profit after tax of NT$21,788 thousand. If it is assumed that this acquisition occurred on January 1, 2024, the pro forma net operating revenue and net profit after tax for the Group from January 1 to September 30, 2024, would increase by NT$481,423 thousand and NT$74,374 thousand, respectively.

(10) Property, Plant and Equipment

The changes in costs, depreciation and impairment loss of the Group’s property, plant and equipment were as follows:

Cost or deemed cost:
Balance on January 1, 2024
Acquired by combinations
Additions
Disposal
Reclassification (Note 1)
Effect of changes in exchange rate
Balance on September 30, 2024
Balance on January 1, 2023
Additions
Disposal
Reclassification (Note 2)
Effect of changes in exchange rate
Balance on September 30, 2023
Depreciation and impairment loss:
Balance on January 1, 2024
Acquired by combinations
Depreciation
Disposal
Reclassification
Effect of changes in exchange rate
Balance on September 30, 2024
Balance on January 1, 2023
Depreciation
Disposal
Reclassification
Effect of changes in exchange rate
Balance on September 30, 2023
Carrying amount:
Balance on September 30, 2024
Balance on January 1, 2024
Balance on September 30, 2023
Land Buildings
and
Structures
Machinery
and
Equipment
Transportation
Equipment
Office
Equipment
Other
Equipment
Construction
in Process
Total
$ 2,175,269
928,452
-
-
-
3,481

3,340,695

499,841

19,170

(3,343)

16,146

12,572
3,821,343
531,822
36,910
(13,010)
17,321
10,738

43,651

1,245

11,526

(9,134)

-

123

178,375

8,970

1,268

(167)

5,791

1,114
717,456
84,998
18,234
(745)
2,657
93
71,901
7,684
56,683
-
(39,528)
-
10,348,690
2,063,012
143,791
(26,399)
2,387
28,121
$
3,107,202

3,885,081
4,405,124
47,411

195,351
822,693 96,740 12,559,602
$ 2,176,957
-
-
-
3,037

3,294,449

10,462

(333)

10,877

12,702
3,777,621
23,558
(4,108)
35,686
14,423

43,730

801

(819)

-

61

176,776

4,173

(2,746)

190

1,810
709,903
5,460
(3,419)
872
157
100,600
8,748
-
(22,376)
-
10,280,036
53,202
(11,425)
25,249
32,190
$
2,179,994

3,328,157
3,847,180
43,773

180,203
712,973 86,972 10,379,252
$ -
-
-
-
-
-
2,592,859

403,018

75,607

(1,457)

-

9,387
3,349,286
475,439
96,146
(13,010)
(379)
9,753

35,899

1,245

2,648

(3,339)

-

104

164,860

6,931

3,860

(167)

-

1,057
668,066
67,936
21,224
(745)
379
65
-
-
-
-
-
-
6,810,970
954,569
199,485
(18,718)
-
20,366
$
-
3,079,414 3,917,235
36,557

176,541
756,925 - 7,966,672
$ -
-
-
-
-
2,500,767

72,088

(333)

(63)

10,334
3,243,639
98,348
(4,108)
(563)
12,936

33,172

2,518

(599)

-

54

163,321

3,219

(2,746)

-

1,712
641,815
22,678
(3,419)
563
106
-
-
-
-
-
6,582,714
198,851
(11,205)
(63)
25,142
$
-
2,582,793 3,350,252
35,145

165,506
661,743 - 6,795,439
$
3,107,202

805,667
487,889
10,854

18,810
65,768 96,740 4,592,930
$
2,175,269

747,836
472,057
7,752

13,515
49,390 71,901 3,537,720
$
2,179,994

745,364
496,928
8,628

14,697
51,230 86,972 3,583,813

Note 1: An amount of NT$2,746 thousand was transfer in from other non-current assets, and NT$359 thousand as expenses. Note 2: Transfer in from prepaid equipment payments.

Details of borrowings and financing facilities guaranteed as of September 30, 2024, December 31, 2023 and September 30, 2023 are provided in Note 8.

24

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(11) Right-of-Use Assets

The changes in the costs, depreciation, and impairment loss of land, buildings and structures, transportation equipment and machinery equipment leased by the Group were as follows:

Cost of Right-of-Use Assets:
Balance on January 1, 2024
Acquired by combinations
Additions
Decrease in the period
Effect of changes in exchange rate
Balance on September 30, 2024
Balance on January 1, 2023
Additions
Effect of changes in exchange rate
Balance on September 30, 2023
Depreciation and impairment losses of
right-of-use assets:
Balance on January 1, 2024
Acquired by combinations
Depreciation
Decrease in the period
Effect of changes in exchange rate
Balance on September 30, 2024
Balance on January 1, 2023
Depreciation
Effect of changes in exchange rate
Balance on September 30, 2023
Carrying amount:
Balance on September 30, 2024
Balance on January 1, 2024
Balance on September 30, 2023
Land,
Buildings and
Structures
$ 46,204
7,908
10,501
(7,333)
754
$
58,034
$ 46,255
-
1,538
$
47,793
$ 24,963
6,370
5,256
(5,763)
462
$
31,288
$ 18,659
4,864
618
$
24,141
$
26,746
$
21,241
$
23,652
Transportation
Equipment
32,666
2,693
28,535
(20,257)

-
43,637
29,709
854
-
30,563
25,444
2,693
7,157
(16,463)
-
18,831
17,239
6,176

-
23,415
24,806
7,222
**7,148 **
Machinery
and
Equipment
Total

352

-

-

-

-
79,222
10,601
39,036
(27,590)
754

352
102,023

4,375

-

(280)
80,339
854
1,258

4,095
82,451

140

-

53

-

-
50,547
9,063
12,466
(22,226)
462

193
50,312

3,935

53

(270)
39,833
11,093
348

3,718
51,274

159
51,711

212
28,675

377
31,177

(12) Investment Properties

Investment Properties
Carrying amount:
Balance on September 30, 2024
Balance on January 1, 2024
Balance on September 30, 2023
Land, Buildings and Structures
$
30,583
$
30,782
$
31,682

There were no significant additions, disposals, impairments, or reversals of investment properties for the Group during the periods from January 1 to September 30, 2024 and 2023. For other related information, please refer to Note 6(12) of the 2023 consolidated financial statements.

The fair value of the Group's investment properties does not significantly differ from the information disclosed in Note 6(12) of the 2023 consolidated financial statements.

25

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(13) Intangible assets

Details of the cost, amortization, and impairment losses changes for intangible assets of the Group are as follows:

Cost:
Balance on January 1,
2024
Acquired by combinations
Acquired separately
Effect of changes in
exchange rate
Balance on September 30,
2024
Balance on January 1,
2023
Acquired separately
Transfer from other non-
current assets
Effect of changes in
exchange rate
Balance on September 30,
2023
Amortization and impairment
losses:
Balance on January 1,
2024
Acquired by combinations
Amortization
Balance on September 30,
2024
Balance on January 1,
2023
Amortization
Effect of exchange rate
changes
Balance on September 30,
2023
Carrying amount:
Balance on September 30,
2024
Balance on January 1,
2024
Balance on September 30,
2023
Computer
Software
$ 132,767
120
98
-
$
132,985
$ 132,616
1,170
290
(76)
$
134,000
$ 131,678
96
598
$
132,372
$ 119,795
10,915
(137)
$
130,573
$
613
$
1,089
$
3,427
Trademark
42,377

-
502
-
42,879
41,053
865
-
-
41,918
35,087

-
1,076
36,163
33,643
1,073
-
34,716
6,716
7,290
7,202
Goodwill
-
30,523
-
-
30,523
-
-
-
-
-
-
-
-
-
-
-
-
-
30,523
-
-
Others
33,586

4,000

-
1
37,587
33,594

-
-
(71)
33,523
33,418

2,533
133
36,084
33,085

333
-
33,418
1,503
168
105
Total
208,730

34,643

600
1
243,974
207,263

2,035
290
(147)
209,441
200,183

2,629

1,807
204,619
186,523

12,321
(137)
198,707
39,355
8,547
10,734

As of September 30, 2024, December 31, 2023 and September 30, 2023, the Group's intangible assets were not pledged as collateral.

The amortization expenses for intangible assets from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023, are detailed in the income statement as follows:

Operating Costs
Operating expenses
July to
September, 2024
July to
September, 2023
January to
September, 2024
January to
September, 2023
$
8

-

27

586
$
588

3,313

1,780

11,735

26

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(14) Short-Term Borrowings

The details, terms, and conditions of the Group's short-term borrowings are as below:

Secured bank loans
Unsecured bank loans
Total
Unutilized amount
Interest Rate Range (%)
9.30.2024
$ 335,562
535,558
$
871,120
$
2,383,507
**0.75~5.86 **
12.31.2023

427,411

550,000

977,411

2,325,793

0.47~6.56
9.30.2023

440,867

670,000

1,110,867

2,179,601

0.49~6.62

Please refer to Note 8 for the Group’s pledged assets as collaterals for bank borrowings.

(15) Long-Term Borrowings

The details, terms, and conditions of the Group's long-term borrowings are as below:

Secured bank loans
Unsecured bank loans
Subtotal
Less: due within one year
Unutilized amount
9.30.2024
Interest Rate
Range (%)
1.10~2.22
1.18~1.82
Year of
Maturity
2025~2030
2026

Amount
$ 113,507
396,600
510,107
(96,893)
$
413,214
$
1,022,793
Secured bank loans
Unsecured bank loans
Subtotal
Less: due within one year
Unutilized amount
Secured bank loans
Unsecured bank loans
Subtotal
Less: due within one year
Unutilized amount
Interest Rate
Range (%)
0.85~1.10
1.05~1.76
Interest Rate
Range (%)
1.10
1.05~1.76
12.31.2023
Year of
Maturity
2025
2025~2026


9.30.2023
Amount
$ 1,947
241,600
243,547
(1,551)
$
241,996
$
1,135,613
Year of
Maturity
2025
2025~2026

Amount
$ 2,718
241,600
244,318
(1,938)
$
242,380
$
1,456,361

Please refer to Note 8 for the Group’s pledged assets as collaterals for bank borrowings.

27

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(16) Lease Liabilities

The carrying amounts of the Group’s lease liabilities are as follows:

Current
Non-current
Total
9.30.2024
$ 16,298
24,356
$
40,654
12.31.2023
8,545
8,408
16,953
9.30.2023
9,714
9,033
18,747

Please refer to Note 6(25) Financial instruments for maturity analysis.

The amounts of leases recognized in profit or loss are as follows:

Interest expense of lease
liabilities
Expenses for short-term leases
Expenses related to low-value
lease assets
July to
September,
2024
July to
September,
2023

118

251

**343 **
January to
September,
2024

332

1,721

15,765
January to
September,
2023
$
**158 **
419
$
**470 **

1,686
$
**4,281 **
5,789

The amounts of leases recognized in the cash flow statement are as follows:

Total cash outflow for leases January to
September, 2024
$
29,653
January to
September, 2023

18,484
  • 1) Lease of Land, Buildings, and Construction

Prior to commencement of the lease, a subsidiary in the mainland region leased land for the use of plants from the People's Republic of China under prepaid rent with terms of 41 years, the right-of-use assets are transferred upon obtaining the land certificate with fixed amortization of installments during the lease period.

The Group also leases a number of land and buildings for use as plants and offices. The lease terms range from 2 to 10 years. At the end of the lease term, the Group has no preferential right to acquire the leased building.

2) Other Lease

The Group leases a number of machines and transportation equipment for business use, and their lease terms range from 2 to 4 years. At the end of the lease term, the lease agreement does not entitle the Group to renew the lease agreements or acquire the assets.

The Group elects to apply the recognition exemptions to leases of various office equipment and other equipment that qualify as low-value asset leases, and thus did not recognize right-of-use assets and lease liabilities for these leases.

28

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • (17) Employee Benefits

1) Defined benefit plans

As there were no significant market fluctuations, curtailments, settlements, or other significant one-off events after the end of the previous financial year, the Group used the pension cost rates determined by actuarial valuations as of December 31, 2023, and 2022, to measure and disclose pension costs for the interim period.

The pension expenses recognized by the Group under the defined benefit plans from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 were NT$369 thousand, NT$508 thousand, NT$932 thousand and NT$1,369 thousand, respectively.

The Group's appointed managers contribute 1% of their total salary monthly to retirement pension reserves. The pension costs recognized by the Group under the above pension plan from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 were NT$1,589 thousand, NT$1,552 thousand, NT$4,792 thousand and NT$4,657 thousand, respectively.

2) Defined contribution plans

The pension system applicable to the Group under the “Labor Pension Act” is a defined contribution plan under government administration, to which the Group contributes 6% of employees' monthly salary and wages to their personal accounts at the Bureau of Labor Insurance. The pension costs recognized by the Group under the above pension plan from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 were NT$13,889 thousand, NT$12,394 thousand, NT$39,103 thousand and NT$36,612 thousand, respectively.

(18) Income Tax

Details of the Group’s income tax expenses for the periods from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 are as follows:

Current tax expenses
Current income tax expenses
Current income tax from prior
years adjustment
Deferred tax expenses
Origination and reversal of
temporary differences
Tax expenses
July to
September,
2024
July to
September,
2023
January to
September,
2024
January to
September,
2023
$ 94,586
-

56,011
-

254,320
16,711

178,304
(202)
94,586
56,011

271,031

178,102
21,358 23,680 67,611 38,345
$
115,944

79,691

338,642

216,447

29

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

Details of the income tax expenses (benefits) recognized in other comprehensive income by the Group from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 are as follows:

Items that may be reclassified
subsequently to profit or loss:
Exchange differences on
translating foreign operations
July to
September,
2024
$
23,336
July to
September,
2023

8,888
January to
September,
2024

28,971
January to
September,
2023
(6,339)

The Corporation income tax return has been approved by the Tax authorities up to the fiscal year 2022.

  • (19) Capital and Other Equities

Except as described below, there were no significant changes in the Group’s capital and other equity accounts during the periods from January 1 to September 30, 2024 and 2023. Please refer to Note 6(19) of the 2023 consolidated financial statements for relevant information.

1) Retained earnings

The Corporation passed the 2023 and 2022 profit distribution proposal by the board of directors on March 27, 2024, and March 29, 2023, respectively. According to the Corporation's articles of association, the cash dividend is authorized to the board of directors to make a special resolution, while the remaining profit distributions were resolved by the shareholders' meeting on May 29, 2024 and May 25, 2023. The dividends distributed to owners are as follows:

dividends distributed to owners are as follows:
Dividends distributed to owners of ordinary shares:
Cash
Distribution ratio (NT$)
2023
$
612,773
$
2.30
2022
612,773
2.30

Information related to earning distribution resolved by the Corporation's Board of Directors and shareholders’ meeting is available on the Market Observation Post System website of the Taiwan Stock Exchange.

30

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

2) Treasury shares

Yung Shin Pharmaceutical's subsidiary, Angel Associates (Taiwan), Inc. (hereinafter referred to as Angel Associates), acquired 55 thousand shares of Yung Shin Pharmaceutical before the amendment to the Company Act on November 12, 2001. The purpose of holding shares is solely for investing.

On January 3, 2011, Yung Shin Pharmaceutical was established by the Corporation through share swap and Yung Shin Pharmaceutical became a wholly-owned subsidiary of the Corporation. According to Order Tai-Cai-Zheng-3-Zi No. 0920124301, the shares of Yung Shin Pharmaceutical held by Angel Associates (Taiwan), Inc. were exchanged into the shares of the Corporation through a share swap.

Angel Associates acquired new shares issued from the Company's capitalization of retained earnings on September 5, 2015. As of September 30, 2024, December 31, 2023, and September 30, 2023, Angel Associates held 58 thousand shares of the Corporation.

The book value of the Corporation's shares held by Angel Associates is NT$1,958 thousand and the market prices as of September 30, 2024, December 31, 2023, and September 30, 2023, were NT$3,565 thousand, NT$2,700 thousand, and NT$2,555 thousand, respectively.

The subsidiaries holding treasury shares are bestowed shareholders' rights, except the rights to participate in any share issuance for cash and to vote.

  • (20) Share-Based Payments

Except as described below, there were no significant changes in the Group’s share-based payment during the periods from January 1 to September 30, 2024 and 2023. For related information, please refer to Note 6(20) of the 2023 consolidated financial statements.

Detailed information on the employee stock option plan of the subsidiary Vetnostrum Animal Health is provided below:

Outstanding as of January 1
Quantity of options granted
Quantity of options lost
Outstanding as of September 30
Exercisable as of September 30
January to September, 2024
Weighted
Average
Exercise Price
(In Currency
Units)
Quantity of
Stock Option
$ 16.50
101
16.50
(50)
-
-
16.50
51
16.50
51
January to September, 2023 January to September, 2023
Weighted
Average
Exercise Price
(In Currency
Units)
$ 16.50
16.50
-
16.50
16.50
Weighted
Average
Exercise Price
(In Currency
Units)
16.50
16.50
-
16.50
16.50
Quantity of
Stock Option
193
(77)
(15)
101
101

31

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

From January 1, 2024 to September 30, 2024, the employees of Vetnostrum Animal Health Co., Ltd. have executed 50 thousand shares at subscription price of NT$16.5 per share and collected proceeds of NT$825 thousand. On March 7, 2024 and August 2, 2024, the board of directors resolved March 7, 2024 and August 2, 2024 as the record date for capital increase, respectively. As of April 1, 2024 and August 28, 2024, the relevant legal registration procedures have been completed and the number of all issued shares have been received.

During January 1, 2023 to August 8, 2023, the employees of Vetnostrum Animal Health Co., Ltd. have executed 77 thousand shares at a subscription price of NT$16.5 per share and collected proceeds of NT$1,271 thousand. On August 8, 2023, the board of directors resolved August 8, 2023 as the record date for capital increase, while the relevant statutory change registration procedures were completed on September 8, 2023.

(21) Earnings Per Share

The Corporation calculates basic earnings per share and diluted earnings per share as follows:

1) Basic earnings per share

Net profit attributable to ordinary
shareholders of the Corporation
Weighted average ordinary shares
outstanding
Basic earnings per share (NT$)
July to
September,
2024
$
218,468
266,365
$
0.82
July to
September,
2023
January to
September,
2024

820,109
266,365
3.08
January to
September,
2023
241,931 618,133
266,365 266,365
0.91 2.32

2) Diluted earnings per share

Diluted earnings per share
Net profit attributable to ordinary
shareholders of the Corporation
Weighted average ordinary shares
outstanding
Effect of potentially dilutive
ordinary shares
Impact of employee stock
compensation
Weighted average ordinary shares
outstanding (diluted)
Diluted earnings per share (NT$)
July to
September,
2024
$
218,468
266,365
47
266,412
$
0.82
July to
September,
2023

241,931
266,365
48
266,413
0.91
January to
September,
2024

820,109
266,365
65
266,430
3.08
January to
September,
2023
618,133
266,365
68
266,433
2.32

32

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • (22) Revenue from Contracts with Customers

1) Breakdown of revenue

Major regional markets:
Taiwan
U.S.A.
China
Japan
Main product/service lines:
Human drugs
Health food
Animal drugs
Others
July to
September,
2024
$ 1,656,318
168,601
18,146
260,708
$
2,103,773
$ 1,273,142
247,366
353,752
229,513
$
2,103,773
July to
September,
2023
1,397,353
114,349
21,870
186,845
1,720,417
1,069,655
237,667
209,211
203,884
1,720,417
January to
September,
2024
4,565,523
593,216
51,252
666,237
5,876,228
3,860,838
623,391
948,038
443,961
5,876,228
January to
September,
2023
4,119,581
374,042
65,366
524,583
5,083,572
3,281,819
603,980
899,834
297,939
5,083,572

2) Contract balance

Notes receivable
Accounts receivable
Accounts receivable from related
parties
Overdue receivable (classified as
other non-current assets)
Less: Loss allowance - notes
receivable
Loss allowance - accounts
receivable
Loss allowance - overdue
receivable (classified as
other non-current assets)
Total
Contract liabilities - current
Customer loyalty programs
Sales revenue received in
advance
Total
Refund Liabilities
Current
Non-current
Total
Contract liabilities - non-current
Customer loyalty programs
Sales revenue received in
advance
Total
9.30.2024
$ 249,821
1,348,539
56,617
-
(231)
(4,873)
-
$
1,649,873
$ -
2,777
$
2,777
$ 23,332
75,557
$
98,889
$ 8,549
350,933
$
359,482
12.31.2023
317,520
1,321,397
51,004
70
(630)
(6,035)
(70)
1,683,256
-
239
239
31,567
75,557
107,124
8,549
350,933
359,482
9.30.2023
306,175
1,222,293
46,650
-
(619)
(6,360)
-
1,568,139
8,549
177
8,726
23,679
142,772
166,451
-
350,933
350,933

Please refer to Note 6(5) for notes receivable, accounts receivable and related impairment.

33

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • (23) Employee Compensations and Directors’ Remuneration

In accordance with the Corporation's Articles of Incorporation, the Corporation shall accrued employees’ compensation and directors’ remuneration at the rate that are not lower than 0.3 and not higher than 2 at profit before tax, respectively. However, if the Corporation has accumulated losses, the amount of the indemnification should be reserved in advance.

Such employees’ compensation may be distributed in the form of stock or cash, and its payable to the employees of affiliated companies who meet the criteria established by the Board of Directors. The aforementioned remuneration of directors shall be paid in cash only.

The estimated amounts of employee compensation from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 were NT$770 thousand, NT$855 thousand, NT$2,884 thousand and NT$2,110 thousand, respectively. The estimated amounts of directors' remuneration were NT$5,138 thousand, NT$4,348 thousand, NT$19,229 thousand and NT$12,714 thousand, respectively. These estimates were based on the pre-tax net profit of the respective periods, before deducting employee and directors' compensation, multiplied by the distribution percentages stipulated in the Corporation's Articles of Incorporation. The amounts were reported as operating expenses for the respective periods. If there is a difference between the actual distribution amount in the following year and the estimated amount, it will be treated as a change in accounting estimate and the difference will be recognized in the profit or loss of the following year.

The estimated amounts for employee compensation for the years 2023 and 2022 were NT$2,695 thousand and NT$2,708 thousand, respectively. The estimated amounts for director compensation were NT$17,969 thousand and NT$18,053 thousand for the years 2023 and 2022, respectively. These estimations are based on the Group's pre-tax net profit deducted by the amounts of employee and director compensation multiplied by the distribution rates prescribed in the Company's Articles of Association, and are reported as operating expenses for the years 2023 and 2022. Related information can be found on the Market Observation Post System. The amounts of employee and director compensation distributed in accordance with the aforementioned board resolutions do not differ from the estimated amounts in the Company's financial reports for the years 2023 and 2022.

  • (24) Non-Operating Income and Expenses

1) Interest income

Interest income
Interests on bank
deposits
July to
September,
2024
$
11,096
July to
September,
2023
January to
September,
2024

39,557
January to
September,
2023
13,627 37,748

34

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

2) Other income

Other income
Rental income
Royalty income
Dividend income
Other income
July to
September,
2024
$ 316
308
4,936
6,124
$
11,684
July to
September,
2023
January to
September,
2024
3,090
1,203
4,936
16,844
26,073
January to
September,
2023

1,392

-

116

64,885
2,377
-
116
73,726

66,393
76,219
  • 3) Other gains and losses
Gain (loss) on disposal of
property, plant and
equipment
Gain on re-measurement
of investment
Gains on lease
modifications
Foreign exchange gain
(loss), net
Depreciation of
investment properties
Others
July to
September,
2024

$ (1,886)
-
17
(18,937)
(293)
(1,220)
$
**(22,319) **
July to
September,
2023
January to
September,
2024
(884)
113,185
17
35,275
(886)
(815)
145,892
January to
September,
2023
(1)
-
-
46,902
(309)

406
218
-
-
53,318
(1,065)
(353)

46,998
52,118
  • 4) Finance costs
Finance costs
Interest on bank loans
Lease liabilities interests
July to
September,
2024
$ 8,096

158
$
8,254
July to
September,
2023

8,805

118

8,923
January to
September,
2024

22,074

332

22,406
January to
September,
2023

25,847

419

26,266
  • (25) Financial Instruments

  • 1) Credit risk

    • a. Exposure to credit risk

The carrying amount of financial assets represents the maximum amount of credit risk exposure.

  • b. Concentration of credit risk

The accounts receivable of the Group cover a large number of customers and spread across different industries and geographical regions. The Group continuously evaluates the business and financial status of the customers and monitors the collection of accounts receivable.

35

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

2) Liquidity risk

The table below shows the contractual maturity dates for financial liabilities, including the effect of estimated interests but excluding net amount agreements.

September 30, 2024
Non-derivative financial
liabilities
Short-term borrowings
Notes payable
Accounts payable (including
related parties)
Other payables
long-term borrowings
(including those due within
one year)
Lease liabilities
Deposits received
December 31, 2023
Non-derivative financial
liabilities
Short-term borrowings
Notes payable
Accounts payable (including
related parties)
Other payables
long-term borrowings
(including those due within
one year)
Lease liabilities
Deposits received
September 30, 2023
Non-derivative financial
liabilities
Short-term borrowings
Notes payable
Accounts payable (including
related parties)
Other payables
long-term borrowings
(including those due within
one year)
Lease liabilities
Deposits received
Carrying
Amount
Contractual
Cash Flow
Within 1
Year
1-2 Years 2-5 Years Above 5
Years
$ 871,120
8,100
636,356
786,327
510,107
40,654
247

877,501

8,100
636,356

786,327
526,635

42,689

247

877,501

8,100
636,356

786,327
103,218

17,650

-
-
-
-
-
369,494
13,296
-

-

-

-

-

53,923

11,743
-

-

-
-

-
-

-
247
$
**2,852,911 **

**2,877,855 **

2,429,152
382,790 65,666 247
$ 977,411
1,514
557,245
709,102
243,547
16,953
270

987,148

1,514
557,245

709,102
249,535

20,344

270

987,148

1,514
557,245

709,102
4,869

10,340

-
-
-
-
-
112,203
9,295
-

-

-

-

-

132,463

709
-

-

-
-

-
-

-
270
$
**2,506,042 **

**2,525,158 **

2,270,218
121,498 133,172 270
$ 1,110,867
5,243
579,247
642,080
244,318
18,747
280

1,132,200

5,243
579,247

642,080
251,328

19,994

280

1,132,200

5,243
579,247

642,080
5,285

10,128

-
-
-
-
-
113,232
5,827
-

-

-

-

-

132,811

3,823
-

-

-
-

-
-

216
280
$
**2,600,782 **

**2,630,372 **

2,374,183
119,059 136,634 496

The Group does not expect the timing of cash flows for the maturity analysis to be significantly earlier or the actual amounts to be significantly different.

36

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

3) Currency risk

  • a. Exchange rate risk exposure

The Group's financial assets and liabilities exposed to material exchange rate risk were as follows:

9.30.2024 12.31.2023 12.31.2023 9.30.2023
Financial Assets Foreign
Currency
Exchange
Rate
TWD Foreign
Currency
Exchange
Rate
TWD Foreign
Currency
Exchange
Rate
TWD
$ 42,756
27,321
333,721
5,551
-
6,006
295
31.65
4.52
0.22
31.65
-
0.22
35.38
1,353,229
123,401
74,186
175,698
-
1,335
10,434
30,298
26,098
166,177
2,811
-
4,822
34
30.71
4.34
0.22
30.71
-
0.22
33.98
930,285
113,142
36,094
86,324
-
1,046
1,144
36,324
19,350
171,801
2,963
109
1,600
-
32.27
4.49
0.22
32.27
4.49
0.22
-
1,172,161
86,971
37,143
95,629
491
346
-
Monetary items
USD
RMB
JPY
Financial Liabilities
Monetary items
USD
RMB
JPY
EUR
  • b. Sensitivity analysis of exchange rate

The Group’s exchange rate risk primarily from cash and cash equivalents, accounts receivable (including related parties), other accounts receivable, accounts payables (including related parties), and other accounts payables in foreign currencies, and foreign exchange gains and losses arise during translation. As of September 30, 2024 and 2023, assuming the New Taiwan Dollar appreciates or depreciates by 1% against the US Dollar, Japanese Yen, Chinese Yuan, and Euro, while all other factors remain constant, the pre-tax net profit for the periods from January 1 to September 30, 2024 and 2023 would increase or decrease by NT$13,633 thousand and NT$11,998 thousand, respectively. The same basis was used for analyses for both periods.

  • c. Foreign exchange gains and losses on monetary items

Due to the diverse functional currencies within the Group, information on foreign exchange gains or losses on monetary items is disclosed on an aggregated basis. For the period of July 1 to September 30, 2024 and 2023, and January 1 to September 30, 2024 and 2023, the foreign exchange (losses) gains (including realized and unrealized) were NT$(18,937) thousand, NT$46,902 thousand, NT$35,275 thousand and NT$53,318 thousand, respectively.

4) Interest rate analysis

The following sensitivity analysis is determined by the interest rate risk exposure of non-derivative instruments on the reporting date. For financial instruments with floating interest rates, the analysis is based on the assumption that the outstanding liabilities on the reporting date have been outstanding all year round. The rate of change used internally in reporting interest rates to the management from the Group is 0.1% increase or decrease in interest rates, which represents the management's evaluation of the reasonable range of possible changes in interest rates.

37

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

If the interest rate increases or decreases by 0.1 with all other variables held constant, the pre-tax net profit for the periods from January 1 to September 30, 2024 and 2023, would decrease or increase by approximately NT$897 thousand and NT$812 thousand, respectively, primarily due to fluctuations in the Group's variable-rate bank borrowings.

  • 5) Other price risks

If the price of equity securities changes on the reporting date (adopt the same basis of analysis for both periods, with the assumption that other variable factors remain unchanged), the impact on comprehensive income items were as follows:

Securities Price on Reporting Date January to
September, 2024
$
1,870
$
(1,870)
January to
September, 2023
Increase of 1%
Decrease of 1%

619

(619)

6) Fair value information

  • a. Categories and fair value of financial instruments

The Group's financial assets at fair value through profit or loss through other comprehensive income are measured at fair value on a recurring basis. The carrying amount and fair value of financial assets and liabilities (including information of fair value hierarchy; however, the fair value of financial instruments not at fair value and whose carrying amounts are reasonable approximations of their fair value and lease liabilities is not required to be disclosed) were as follows:

Financial assets at FVTPL
Non-derivative financial assets
mandatorily measured at FVTPL
Financial assets at FVTOCI
Listed shares
Unquoted equity instruments
measured at fair value
Subtotal
Financial assets at amortized cost
Cash and cash equivalents
Financial assets at amortized cost
Notes receivable and accounts
receivable (including related
parties)
Other receivables
Refundable deposits
Subtotal
Total
Financial liabilities at amortized cost
Bank loans
Notes payable and accounts payable
(including related parties)
Other payables
Lease liabilities
Deposits received
Total
9.30.2024 9.30.2024 9.30.2024
Carrying
Amount
Fair Value
Level 1 Level 2 Level 3 Total
$ 105,482 - - 105,482 105,482
$ 8,652
178,383

8,652
-

-
-

-
178,383

8,652
178,383
187,035
8,652

-

178,383

187,035
1,673,607
317,058
1,649,873
26,607
166,935

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-
3,834,080
-

-

-

-
$
4,126,597

8,652

-

283,865

292,517
$ 1,381,227
644,456
786,327
40,654
247

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-
$
2,852,911

-

-

-

-

38

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

Financial assets at FVTPL
Non-derivative financial assets
mandatorily measured at FVTPL
Financial assets at FVTOCI
Listed shares
Unquoted equity instruments
measured at fair value
Subtotal
Financial assets at amortized cost
Cash and cash equivalents
Financial assets at amortized cost
Notes receivable and accounts
receivable (including related
parties)
Other receivables
Refundable deposits
Subtotal
Total
Financial liabilities at amortized cost
Bank loans
Notes payable and accounts payable
(including related parties)
Other payables
Lease liabilities
Deposits received
Total
Financial assets at FVTPL
Non-derivative financial assets
mandatorily measured at FVTPL
Financial assets at FVTOCI
Listed shares
Unquoted equity instruments
measured at fair value
Subtotal
Financial assets at amortized cost
Cash and cash equivalents
Financial assets at amortized cost
Notes receivable and accounts
receivable (including related
parties)
Other receivables
Refundable deposits
Subtotal
Total
Financial liabilities at amortized cost
Bank loans
Notes payable and accounts payable
(including related parties)
Other payables
Lease liabilities
Deposits received
Total
12.31.2023 12.31.2023 12.31.2023
Carrying
Amount
Fair Value
Level 1 Level 2 Level 3 Total
$ 105,482 - - 105,482 105,482
7,196
58,873

7,196
-

-
-

-
58,873

7,196
58,873
66,069
7,196

-

58,873

66,069
$ 1,486,926
257,646
1,683,256
26,392
62,970

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-
3,517,190
-

-

-

-
$
3,688,741

7,196

-

164,355

171,551
$ 1,220,958
558,759
709,102
16,953
270

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-
$
2,506,042
-
-

-

-
Carrying
Amount
Fair Value
Level 1 Level 2 Level 3 Total
$ 87,482 - - 87,482 87,482
6,311
55,638

6,311
-

-
-

-
55,638

6,311
55,638
61,949
6,311

-

55,638

61,949
$ 1,433,501
266,282
1,568,139
30,841
67,619

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-
3,366,382
-

-

-

-
$
3,515,813

6,311

-

143,120

149,431
$ 1,355,185
584,490
642,080
18,747
280

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-

-
-

-

-

-
$
2,600,782
-
-

-

-

39

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • b. Valuation technique of fair value

If there is an active market for the financial instrument, the fair value is based on the quoted market price in the active market. The market prices announced by major exchanges are all the basis for the fair value of listed equity instruments.

If the publicly quoted price can be timely and regularly obtained from the stock exchange, broker, underwriter, industrial union, pricing service institution or competent authority, and the price represents actual and regular transaction at fair market, then the financial instrument is deemed to have the publicly quoted price at the active market. If the above conditions are not met, the market is deemed inactive. Generally speaking, a large difference in buying and selling price, a significant increase in buying and selling price, and few transactions are indexes of a non-active market.

The fair value of financial instruments held by the Group that are traded in an active market are presented by category and attribute as follows:

  • The fair value of the listed stocks, which are financial assets with standard terms and conditions and traded in an active market, is determined based on market prices respectively.

Except for the above-mentioned financial instruments with active markets, the fair value of other financial instruments is obtained through valuation techniques or with reference to the quoted prices of counterparties. For the fair value obtained through the valuation techniques, the Company refers to the current fair value of other financial instruments with similar conditions and characteristics, the discounted cash flow method, or other valuation techniques, including calculations using models based on the market information available at the consolidated balance sheet date.

The fair value of financial instruments held by the Group that are not traded in an active market are presented by category and attribute as follows:

  • Non-derivative financial assets without quoted prices: Their fair value is estimated using the discounted cash flow method and the net asset value method.

  • Non-quoted equity instruments: Their fair value is estimated using the market comparable approach, with the primary assumption based on the price-to-net asset value multiplier derived from the invested entity's net asset value and the market quotations of comparable listed (OTC) companies. This estimate of the equity securities has been adjusted for the effect of lack of market liquidity.

40

YUNGSHIN GLOBAL HOLDING CORPORATION

Notes to Consolidated Financial Statements (Continued)

  • c. Detailed statement of changes in Level 3
January 1, 2024
Total gains or losses
Recognized in other
comprehensive income
Acquired by combinations
September 30, 2024
January 1, 2023
Total gains or losses
Recognized in other
comprehensive income
Purchase
September 30, 2023
Measured at
FVTPL
$ 105,482
-
-
$
105,482
$ 63,482
-
24,000
$
87,482
Measured at
FVTOCI

58,873
(24,002)

143,512
178,383

45,600
10,038

-
**55,638 **
Total

164,355
(24,002)

143,512

283,865

109,082
10,038

24,000

143,120
  • d. Quantitative information on fair value measurement of significant unobservable inputs (Level 3).

The Level 3 of fair value measurements mainly includes financial assets measured at FVTOCI and non-derivative financial assets mandatorily at FVTPL.

The Group's equity instrument investment with no active market has multiple significant unobservable inputs. Significant unobservable inputs for investments in equity instruments with no active market are not correlated with each other because they are independent of each other.

Since the correlation between significant unobservable input value and fair value cannot be fully identified in practice, the Group's investment agreements for product development are not included in the disclosure of quantitative information of significant unobservable input values and the sensitivity analysis of fair value for reasonably possible alternative assumptions.

41

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

Quantitative information on significant unobservable inputs is listed as follows:

follows:
Item Valuation
Technique
Significant
Unobservable Input
Relationship Between
Significant
Unobservable Input
and the Fair Value
Financial assets at
fair value through
other
comprehensive
income -
investments in
equity instruments
with inactive
market
Financial assets
measured at fair
value through profit
or loss - Private
equity fund
investments
Market approach
(approach
comparable to
listed companies)
Net asset value
method
 Multiplier of price-to-
book ratio (as of
9.30.2024,
12.31.2023 and
9.30.2023, ranging
from 1.22 to 2.15,
from 0.82 to 1.75,
and from 0.73 to
1.68, respectively)
 Lack of marketability
discount (35% as of
both 9.30.2024,
12.31.2023, and
9.30.2023)
 Net asset value
 The higher the
multiplier, the
higher the fair value
 The higher the
discount for lack of
marketability, the
lower the fair value
 The higher the net
asset value, the
higher the fair value
  • e. For Level 3 fair value measurements, possibly used of alternative assumptions for sensitivity analysis of fair value.

The measurement of fair values of financial instruments by the Group is reasonable, but the use of different valuation models or valuation parameters may result in different valuation results.

42

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

For financial instruments classified as Level 3, if the valuation parameters change, the effect on other comprehensive income in this period is as follows:

September 30, 2024
Financial assets at FVTOCI
Investments in equity
instruments with
inactive market


December 31, 2023
Financial assets at FVTOCI
Investments in equity
instruments with
inactive market


September 30, 2023
Financial assets at FVTOCI
Investments in equity
instruments with
inactive market

Inputs


Multiplier of
price to book
ratio
Lack of
marketability
discount

Multiplier of
price to book
ratio
Lack of
marketability
discount

Multiplier of
price to book
ratio
Lack of
marketability
discount
Upward or
Downward
Change
5%
5%
5%
5%
5%
5%
Changes in Fair Value
Reflected in Other
Comprehensive Income
Changes in Fair Value
Reflected in Other
Comprehensive Income
Favorable
Change
Unfavorable
Change
$ 8,889
13,736
$ 2,912
4,534
$ 2,788
4,275
(8,889)
(13,736)
(2,912)
(4,534)
(2,788)
(4,275)

The Group’s favorable and unfavorable changes refer to the fluctuations of fair values, and fair values are calculated with the valuation techniques based on different unobservable inputs. If the fair value of a financial instrument is affected by more than one input value, the statement above reflects the effect of changes in the single input value, without taking the correlation and variability between the input values into account.

There were no transfers in the fair value hierarchy of financial assets for the periods from January 1 to September 30, 2024 and 2023.

43

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • (26) Financial Risk Management

There were no significant changes in the Group's financial risk management objectives and policies compared to those disclosed in Note 6(26) of the 2023 annual consolidated financial statements.

  • (27) Capital Management

The Group's capital management objectives, policies, and procedures are consistent with those disclosed in the 2023 annual consolidated financial statements. Additionally, there were no significant changes in the aggregated quantitative data of the items managed as capital compared to the information disclosed in the 2023 annual consolidated financial statements. For related information, please refer to Note 6(27) of the 2023 annual consolidated financial statements.

  • (28) Non-Cash Transaction in Investment and Financing Activities

  • 1) The Group's non-cash investing and financing activities for the periods from January 1 to September 30, 2024 and 2023, involved acquiring right of use assets through leasing arrangements. For details, please refer to Note 6(11).

  • 2) The reconciliation of liabilities from financing activities is as follows:

long-term borrowings
Short-term borrowings
Lease liabilities
Total liabilities from
financing activities
1.1.2024 Cash Flow **Non-C ** ash Changes
9.30.2024
Additions Decrease Additions Disposal Acquired by
Combinations

Changes in
Exchange Rates
$ 243,547
977,411
16,953
265,000
1,513,630
-
(127,567)
(1,634,787)
(11,835)
-
-
39,036
-
-
(5,381)

129,136

-
1,538
(9)
14,866
343
510,107
871,120
40,654
$ 1,237,911 1,778,630 (1,774,189) 39,036 (5,381)
130,674
15,200 1,421,881
long-term borrowings
Short-term borrowings
Lease liabilities
Total liabilities from
financing activities
1.1.2023 Cash Flow **Non-C ** ash Changes 9.30.2023
Additions Decrease Additions Disposal Changes in
Lease
Changes in
Exchange Rates
$ 247,011
1,554,511
28,240
110,000
262,440
-
(112,403)
(710,516)
(10,590)

-

-

854
-
-
-

-

-
-
(290)
4,432
243
244,318
1,110,867
18,747
$ 1,829,762 372,440 (833,509)
854
- - 4,385 1,373,932

44

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

7. Related Parties Transactions

(1) Related Parties and Their Relationship

The related parties with transactions with the Group during the period covered by these consolidated financial statements are as follows:

Related Party Name Relationship with the Group Yung Zip Chemical Ind. Co., Ltd. (Yung Zip) Associate (Note) Y.S.P. Southeast Asia Holding Bhd. (YSP Associate SAH) Y.S.P. Industries (M) Sdn. Bhd. (YSPI) Associate Taiwan Way Chein Industrial Co., Ltd. Associate (Note) LTC Holding Company Limited (LTC Other related party (Substantial related party) Holding) TC Pharmaceuticals (Jiangsu) Co., Ltd. Other related party (Substantial related party) Fang-Yu Lee Other related party (Directors of the Company) Ling-Jin Lee Other related party (Directors of the Company) Fang-Chuan Lee Other related party (Directors of the Company) Yung Shin Amusement Co., Ltd. Other related party (Substantial related party) Yung Shin Social Welfare Foundation (Yung Other related party (Substantial related party) Shin Social Welfare) TienTe Lee Biomedical Foundation Other related party (Substantial related party) (Biomedical Foundation) Yung Shin Elderly Nursing Home Other related party (Substantial related party) Bio-X Lab Co., Ltd. Other related party (Substantial related party) E & A Health Develop Co., Ltd. Other related party (Substantial related party) Pan Pharm Alliance Co., Ltd. Other related party (Substantial related party)

Note: Yung Zip and its subsidiaries became subsidiaries of the Group after May 30, 2024.

(2) Significant Transactions Between Related Parties

  • 1) Operating revenue
Operating revenue
Relationship with the
Corporation / Related Party

July to
September,
2024
$ 46,856
547
$
47,403
July to
September,
2023

37,595
445
38,040
January to
September,
2024

145,160
725
145,885
January to
September,
2023
118,260
982
119,242
Associate
Other related parties

Except for the transaction with YSPI that has no similar type of transactions to be compared with, the prices of other sales above are the same as the general sale. The collection to related parties has no material difference with those sale of goods to third parties.

45

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

2) Purchase of goods

Relationship with the
Corporation / Related Party

July to
September,
2024
$ 1,300
1,815
$
3,115
July to
September,
2023


14,260
-

**14,260 **
January to
September,
2024

26,144
4,980
31,124
January to
September,
2023
Associate
Other related parties
38,509
1,449
39,958

The aforementioned purchasing price of goods from related parties is based on regular commercial terms and conditions. The payment term is the same as regular suppliers.

3) Receivables from related parties

Financial Statement
Account
Relationship with the
Corporation / Related
Party
9.30.2024
**12.31.2023 ** 9.30.2023
Accounts receivable
Other receivables
Associate
YSPI
Yung Zip
Others
Other related parties
Associate
YSP SAH
Others
Other related parties
$ 56,293
-
-
324
45,160
5,835
4
5
43,658
2,743
-
249
56,617 51,004 46,650
940
-
50
-
1,261
4
577
-
28
990 1,265 605
$
57,607
52,269 47,255

As of September 30, 2024, December 31, 2023, and September 30, 2023, no allowance loss was made for the above receivables.

4) Payables to related parties

Financial Statement
Account
Relationship with the
Corporation /
Related Party

9.30.2024
$ -
2,981
3,721
6,702
961
6,480
7,441
$
14,143
12.31.2023
10,782
975
-
11,757
633
1,177
1,810
13,567
9.30.2023
Accounts payable
Other payables
Associate
Yung Zip
Others
Other related parties
Associate
Other related parties

20,901

1,469

-

22,370

665

2,382

3,047
25,417

46

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

5) Operating expenses

It refers to the donations and other expenses paid by the Group to related parties, and the details were as follows:

Relationship with the
Corporation / Related Party
July to
September,
2024
July to
September,
2023
January to
September,
2024
January to
September,
2023
Associate
Other related parties
Total
$ -
3,731
100

3,633
153
10,771
124
11,129
$
3,731

3,733
10,924 11,253

6) Lease

The Group leased land and buildings from Fang-Yu Lee, Ling-Jin Lee, and Yung Shin Amusement in January 2017, September 2018, August 2022, and April 2024 respectively, and the lease agreements ranging from two to ten years. The total value of the contracts amounted to NT$5,980 thousand. The above rent is based on the agreed price referencing the rental market conditions in the adjacent area. The interest expenses recognized for the lease liabilities arising from the above lease agreements for the periods from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 were NT$14 thousand, NT$4 thousand, NT$34 thousand and NT$15 thousand, respectively. As of September 30, 2024, December 31, 2023 and September 30, 2023, the remaining lease liabilities unpaid amounted to NT$3,505 thousand, NT$1,030 thousand and NT$1,239 thousand, respectively.

7) Rental income

The Group leased out investment properties of land and buildings to associates and substantial related parties. The Group received fixed monthly lease payments according to rental rate for similar assets.

Relationship with the
Corporation / Related Party
July to
September,
2024
July to
September,
2023
January to
September,
2024
January to
September,
2023
Associate
Other related parties
Total
$ -
45
184
45
307
136
533
136
$
45
229 443 669

(3) Key Management Compensation

Key management compensation includes:

Short-term employee benefits
Post-employment benefits
July to
September,
2024
July to
September,
2023
January to
September,
2024
January to
September,
2023
$ 4,824
1
4,583
16
14,875
62
14,130
74
$
4,825
4,599 14,937 14,204

In the short-term employee benefits for the period from January 1 to September 30, 2024, it includes providing a car to the Key management personnel with a cost of NT$8,744 thousand. As of September 30, 2024, its book value was NT$7,627 thousand, recognized as property, plant and equipment and right-of-use assets.

47

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

8. Pledged Assets

The carrying amounts of the Group’s pledged assets are as follows:

Name of Asset Item Pledged as Collateral
9.30.2024
12.31.2023 9.30.2023
Property, plant and
equipment:
Land
Buildings and
structures
Other non-current assets:
Restricted assets
Long-term and short-term
borrowings
Long-term and short-term
borrowings
Natural Gas Guarantees
and Government
Project Subsidies
$ 644,721
74,848
12,000
419,727
48,407
10,500
419,617
49,208
4,000
$
731,569
**478,634 **
472,825

9. Significant Contingent Liabilities and Unrecognized Contract Commitments (1) Capital expenditure contracted for at the balance sheet date but unrecognized is as follows:

9.30.2024
12.31.2023
9.30.2023
Property, plant and equipment
$
108,021
89,722
50,181
The Group appointed other biotechnology companies to authorize and transfer technology
and research and development. Expenses that have not been recognized from signed
contracts are as follows:
9.30.2024
12.31.2023
9.30.2023
Authorization and transfer of
technology and research and
development
$
52,257
48,444
52,803
9.30.2024 12.31.2023 9.30.2023
$
108,021
89,722
50,181
$
52,257
48,444
52,803
  • (2) The Group appointed other biotechnology companies to authorize and transfer technology and research and development. Expenses that have not been recognized from signed contracts are as follows:

Except for aforementioned expenses, royalty to be paid in the future is based on an agreed upon percentage of product sales.

10. Losses due to Major Disasters: None.

11. Significant Subsequent Events: None.

48

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

12. Others

(1) Employee benefits, depreciation, depletion, and amortization expenses by functions are summarized as follows:

By Function
By Nature
July to September, 2024 July to September, 2024 July to September, 2024 July to September, 2023 July to September, 2023 July to September, 2023
Operating
Costs
Operating
Expenses
Total Operating
Costs
Operating
Expenses
Total
Employee benefit
expenses
Salaries
Labor and health
insurance
premiums
Pension expenses
Other employee
benefit expenses
Depreciation (Note)
Amortization
193,480
20,456
7,576
4,659
58,791
8

281,936

23,083

8,271

7,880

15,269

588

475,416

43,539

15,847

12,539

74,060

596

148,357

18,497

6,731

3,504

56,776

-

250,817

21,888

7,723

4,474

13,247

3,313

399,174

40,385

14,454

7,978

70,023

3,313
By Function
By Nature
January to September, 2024 January to September, 2024 January to September, 2024 January to September, 2023 January to September, 2023 January to September, 2023
Operating
Costs
Operating
Expenses
Total Operating
Costs
Operating
Expenses
Total
Employee benefit
expenses
Salaries
Labor and health
insurance
premiums
Pension expenses
Other employee
benefit expenses
Depreciation (Note)
Amortization
524,987
58,862
20,889
11,168
169,759
27

792,775

61,610

23,938

22,538

42,192

1,780
1,317,762

120,472

44,827

33,706

211,951

1,807

441,028

55,898

19,809

8,755

170,559

586

720,069

60,023

22,829

12,620

39,385

11,735
1,161,097

115,921

42,638

21,375

209,944

12,321

Note: The depreciation expenses generated by investment properties for the periods from July 1 to September 30, 2024 and 2023, and from January 1 to September 30, 2024 and 2023 were NT$293 thousand, NT$309 thousand, NT$886 thousand and NT$1,065 thousand, respectively, recognized under other gains and losses.

  • (2) Seasonality of Operations:

The Group’s operations are not affected by seasonal or cyclical factors.

49

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

13. Separately Disclosed Items

  • (1) Information on Significant Transactions

In accordance with the Regulations Governing the Preparation of Financial Reports of Securities Issuers for the period from January 1 to September 30, 2024, the Group is required to disclose additional information regarding significant transactions as follows:

  • 1) Financing provided for others: None.

  • 2) Endorsement or guarantee provided to others:

Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated Unite:Expressedin thousands ofNewTaiwandollars unless otherwise stated
No.
(Note 1)
Company
Name
Endorsee/Guarantee Limits on
Endorsement/
Guarantee
Given on
Behalf of
Each Party
(Note 3)
The Maximum
Endorsement
Guarantee
Balance for the
Current
Period (Note 5)



Outstanding
Endorsement
Guarantee at
End of period
(Note 5)

Actual
Amount
Used
Amount
Endorsed/
Guaranteed
by Collateral
Ratio of
Accumulated
Endorsement/
Guarantee to
Net Equity in
Latest
Financial
Statements



Aggregate
Endorsement/
Guarantee
Limit (Note 4)


Endorsement/
Guarantee
Given by
Parent on
Behalf of
Subsidiaries
Endorsement/
Guarantee
Given by
Subsidiaries
on Behalf of
Parent
Endorsement~~/~~
Guarantee
Given on
Behalf of
Companies in
Mainland
China
Company
Name
Relationship
(Note 2)
0
0
The
Corporation
The
Corporation
Chemix
CTI
2
2
1,473,717
1,473,717
208,962
886,545
208,962
854,550
208,962
126,600

-

-
2.84%
11.60%
3,684,292
3,684,292

Y

Y
N
N
N
N

Note 1: The numbers filled in for the loans provided by the Corporation or subsidiaries are as follows:

  1. The Corporation is “0.”

  2. The subsidiaries are numbered in order starting from “1.”

  3. Note 2: Relationship between the endorser/guarantor and the party being endorsed/guaranteed is classified into the following categories; the number of category in each case belongs to:

  4. Having business relationship.

  5. Companies in which the Corporation directly and indirectly holds more than 50% of the voting shares.

  6. Note 3: The total amount of endorsement and guarantee for a single enterprise by the Corporation shall not exceed 20% of the net value of the most recent financial statement of the Corporation at the time of providing endorsement and guarantee.

  7. Note 4: The total amount of cumulative endorsement and guarantee shall not exceed 50% of the net value of the most recent financial statements of the Corporation.

50

YUNGSHIN GLOBAL HOLDING CORPORATION

Notes to Consolidated Financial Statements (Continued)

  • 3) Marketable securities held at the end of the period (excluding investments in subsidiaries, associates, and joint ventures):
Holding
Company
Name
Type and Name of
Marketable
Securities
Relationship with
the Holding
Company
Financial Statement
Account
September 30, 2024 September 30, 2024 September 30, 2024 September 30, 2024 Remarks
Number of
Shares/Units

Carrying
Amount
Shareholding
Ratio

Fair Value
The
Corporation
Chemix

Yung Shin
Pharmaceutical



Yung Zip

YZP
Oversea
Investment
Co., Ltd.
Angel
Associates
Private Equity Fund -
Forward BioT
Venture Capital
Stock - Sawai
Pharmaceutical Co.,
Ltd.
Stock - Ana Holding
Inc.

Stock - Missioncare
Co., Ltd.
Stock - Missioncare
Asset Management
Co., Ltd.
Stock - Limited
Liability Fengyuan
Medical Waste
Disposal Equipment
Used Cooperatives
Stock - International
Green Handle Co.,
Ltd.
Stock - Missioncare
Co., Ltd.
Stock - Missioncare
Asset Management
Co., Ltd.

LTC Holding
Company Ltd.
Stock - YungShin
Global Holding
Corporation
None
None
None
None
None
None
None
None
None
Other related parties
Parent company
Financial assets at fair
value through profit or
loss - non-current
Financial assets at fair
value through other
comprehensive
income - non-current









Financial assets at fair
value through other
comprehensive
income - current
-
17,595
1,000
3,161,052
1,338,947
1,000
1,567
1,580,526
669,473
2,321,259
58,059

42,000

7,970

682

41,729

21,528

11

20

20,863

10,109

84,123

1,958

6.72%

-
%

-
%

2.17%

2.13%

0.06%

0.07%

1.09%

1.07%

10.19%

0.02%

42,000

7,970

682

41,729

21,528

11

20

20,863

10,109

84,123

1,958











Note

Note: In order to optimize the utilization of working capital held, the carrying amount of this security was transferred to treasury shares.

  • 4) The cumulative amount of acquisition or disposal of the same marketable securities that exceeded NT$300 million or 20% of the paid-in capital: None.

  • 5) Acquisition of individual real estate at costs of at least NT$300 million or 20% of the paid-in capital: None.

  • 6) Disposal of real estate at price in excess of NT$300 million or 20% of the paid-in capital: None.

51

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

  • 7) Total purchases from or sales to related parties amounting to at least NT$100 million or 20% of the paid-in capital:
**Purchaser/Seller ** **Counterparty ** Relationship Transaction Transaction Transaction Transaction Circumstances and Reasons
If the Terms and Conditions
of Trading are Different
from Those in Ordinary
Trading
Circumstances and Reasons
If the Terms and Conditions
of Trading are Different
from Those in Ordinary
Trading

Notes and Accounts Receivable
(Payable)

Notes and Accounts Receivable
(Payable)
Remarks
Purchase or Sale Amount Ratio to
Total
Amount of
Purchases
(or Sales)
Credit
Period
Unit Price
Credit Period
Balance
Ratio to Total
Notes and
Accounts
Receivable
(Payable)
Yung Shin
Pharmaceutical

Vetnostrum Animal
Health Co., Ltd.
Vetnostrum
Animal Health
Co., Ltd.
YSPI
Yung Shin
Pharmaceutical
Other related
parties
Associate
Other related
parties
(Sale)
(Sale)
Purchase of goods
(124,403)
(112,505)
124,403

(3.46)%

(3.13)%

26.78%

Note 1

Note 1

Note 1
-
-
-
-
-
-

73,715

47,609

(73,715)

7.47%

4.83%

(60.61)%

Note 2


Note 2

Note 1: The terms and conditions of the transactions had no apparent difference from other customers. Note 2: All intra-group transactions, are eliminated upon consolidation.

  • 8) Receivables from related parties amounting to at least NT$100 million or 20% of the paid-in capital: None.

  • 9) Derivatives Trading: None.

  • 10) Intercompany Relationships and Significant Intercompany Transactions:

Unit: In Thousands of Ne Unit: In Thousands of Ne w Taiwan Dollars
No.
(Note 1)
Company Name Counterparty Relationship
(Note 2)
Transaction Details
Financial
Statement
Account
Amount
(Note 3)
Payment Terms Ratio to
Consolidated
Revenue or
Total Assets
1
1
1
1
1
2
Yung Shin
Pharmaceutical
Yung Shin
Pharmaceutical
Yung Shin
Pharmaceutical
Yung Shin
Pharmaceutical
Yung Shin
Pharmaceutical
YungShin
TienTe
Vetnostrum
Animal Health
Co., Ltd.
Vetnostrum
Animal Health
Co., Ltd.
Yung Shin
Company Ltd
CTI
CTI
Yung Shin
Pharmaceutical
3
3
3
3
3
3
Accounts
receivable
Sales
Sales
Accounts
receivable
Sales
Sales
73,715
124,403
15,696
12,606
23,970
18,442
No regular
customer available
for comparison
No regular
customer available
for comparison
No regular
customer available
for comparison
No regular
customer available
for comparison
No regular
customer available
for comparison
No regular
customer available
for comparison
0.55%
2.12%
0.27%
0.09%
0.41%
0.31%

Note 1: The number is to be filled in the following manner:

  1. The Corporation is “0.”

  2. The subsidiaries are numbered in order starting from “1.”

Note 2: Types of relationships with traders are listed as follows:

  1. Parent company to subsidiary.

  2. Subsidiary to parent company.

  3. Subsidiary to subsidiary.

Note 3: Business transactions between the Corporation and its subsidiaries amounting to NT$10,000 thousand should be disclosed.

Note 4: All intra-group transactions, are eliminated upon consolidation.

52

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(2) Information on Investees Companies:

Information on the Group's equity method investments for the period from January 1 to September 30, 2024 (excluding mainland China investee companies) is as follows:

Investor
Company
Investee
Company
Location Main Businesses and
Products
Original Investment
Amount
Original Investment
Amount
As of September 30, 2024 As of September 30, 2024 As of September 30, 2024 Net Profit
or Loss of
the Investee
Investment
Gains and
Losses
Recognized
in the
Current
Period
Remarks
September
30, 2024
December
31, 2023
Number of
Shares
% Carrying
Amount
The
Corporation




Yung Shin
Pharmaceutical
Yung Zip


YSP INC

Yung Shin
Pharmaceutical
YSP INC
Vetnostrum
Animal Health
Co., Ltd.
Chemix
Yung Zip

Angel Associates
CTI
YZP Oversea
Investment Co.,
Ltd.
Taiwan Way
Chein Industrial
Co., Ltd. (Taiwan
Way Chein)
CTI
YSP SAH
Yung Shin
CompanyLtd
Taiwan
British
Virgin
Islands
Taiwan
Japan
Taiwan
Taiwan
U.S.A.
British
Virgin
Islands
Taiwan
U.S.A.
Malaysia
Hong Kong
Manufacturing and
sale of medicine and
cosmetics
Trade, investment, and
other related
businesses
Manufacturing and
sale of medicine
Sale of medicine
Manufacture and sale
of active
pharmaceutical
ingredients
Import and export
trading
Manufacturing and
sale of medicine
General investments
Food Manufacturing
Manufacturing and
sale of medicine
Biopharmaceutical
research and technical
services
Sale of medicine
4,151,196
667,496
739,490
270,248
152,968
3,675
25,326
4,658
139,650
806,183
500,615
102,209

4,151,196

667,496

734,708

270,248

152,968

3,675

-
(Note 4)

4,658

139,650

806,183

500,615

102,209
98,166,613

10,000
36,563,975

192

8,817,302

3,675

255,179

159,061

6,650,000

7,502,874
52,365,605

7,720
100.00%
100.00%

55.12%
100.00%

20.81%

73.50%

2.52%
100.00%

70.00%

74.13%

36.92%

96.50%

3,756,431

1,853,657

908,262

416,314

309,280

9,916

14,943

89,855

177,212

337,609

1,137,853

56,200

483,111
(Note 1)

169,069
(Note 2)

100,655
(Note 1)

94,757
(Note 2)

73,221
(Note 1)

2,233
(Note 2)

103,120
(Note 2)

4,663
(Note 2)

12,509
(Note 1)

103,120
(Note 2)

212,273
(Note 2)

2,070
(Note2)

484,591
(Note 1)

166,910
(Note 2)

56,145
(Note 1)

94,746
(Note 2)

13,752
(Note 1)

-

-

-

-

-

-

-

Subsidiary

Subsidiary

Subsidiary

Subsidiary

Subsidiary
(Note 4)
Sub-
subsidiary
Sub-
subsidiary
Sub-
subsidiary
Sub-
subsidiary
Sub-
subsidiary
Associate
Sub-
subsidiary
  • Note 1: Except for Yung Zip and Taiwan Way Chein, whose financial statements have been reviewed by other certified public accountants, the Group recognizes the remaining investment gains and losses based on the financial statements that were measured by using the equity method of the investee companies for the same period, which have been reviewed by the parent company's certified public accountants in Taiwan.

  • Note 2: The investment gains and losses recognized by the Group are based on the financial statements that were measured and recorded by using the equity method of the investee companies for the same period, which were prepared internally and have not been reviewed by auditors.

  • Note 3: Gains or losses on reinvestment of subsidiaries are included in the income of subsidiaries. The transactions between the Corporation and each subsidiary of the Group including sales transaction amount, accounts receivable and payable, carrying amount of long-term equity investment, except for the associates) and investment profit and loss recognized in the current period, have been eliminated in preparing the consolidated financial statements.

  • Note 4: Yung Zip and its subsidiaries became subsidiaries of the Group after May 30, 2024. Additionally, Yung Zip holds 2.52% of CTI, which is subject to accounting policies related to business combinations.

53

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

(3) Information on Investments in Mainland China:

1) Name, principal operation and relevant information of invested companies in the Mainland China:

Investee
Company
Main Businesses
and Products
Paid-in
Capital
(Note 4)
Method of
Investment
(Note 1)
Accumulated
Outward
Remittance for
Investments
from Taiwan
at the
Beginning of
the Period
(Note 4)

Remitted or
Repatriated
Amount of
Investment for the
Period

Remitted or
Repatriated
Amount of
Investment for the
Period
Accumulated
Outward
Remittance for
Investments
from Taiwan
at the End of
the Period
(Note 4)

Net Profit or
Loss of the
Investee
Percentage of
Ownership in
Direct or
Indirect
Investment
Investment
Income (Loss)
(Note 2 and 3)
Carrying
Amount at the
End of the
Period (Note 2
and 3)


Accumulated
Repatriation
of Investment
Income as of
September 30,
2024
Outward
**Remittance **
Inflow
YungShin
TienTe
(Shanghai)
Pharmaceutical
Trading Co.,
Ltd.

International trade,
trade between
companies in the
bonded areas, and
trade agency in the
bonded areas:
Warehousing and
simple commercial
processing in the
bondedareas



121,120

(2)
121,120
-
- 121,120
(182)

100.00%

(182)

90,566
-
  • Note 1: Investment methods are classified into the following three categories, the number of category in each case belongs to:

  • Directly invest in a company in mainland China.

  • Investment in mainland companies through a holding company registered in a third region (YSP International Company Limited)

  • Others

  • Note 2: The amount of long-term equity investment at the end of the period and the investment income (loss) of the current period have been eliminated when the consolidated financial statements are prepared.

  • Note 3: The investment gains and losses as well as the book values disclosed by the Group represent the amounts related to the respective items of direct or indirect investments. The investment income recognized by the Group is based on the financial statements prepared internally of the investee companies, which have not been reviewed by certified public accountants and these gains are recognized using the equity method.

  • Note 4: It is calculated using historical exchange rates.

2) Upper Limit on the Amount of Investment in Mainland China:

Company Name
Accumulated
Outward Remittance
for Investments from
Taiwan to Mainland
China at the End of
the Period
Investment Amounts
Authorized by
Investment
Commission, MOEA
Upper Limit on the
Amount of Investment
Stipulated by the
Investment
Commission, M.O.E.A
The Corporation 121,120
(USD4,000 thousand)
927,029
(USD29,290 thousand)

4,599,744 (Note 1)

Note 1: 60% of the net worth.

  • Note 2: Except for the amount of investment transferred from Taiwan to Mainland China, which is calculated using historical exchange rates, the rest is calculated using the exchange rate at the end of September 30, 2024 (USD:NTD=1:31.650).

  • 3) Material transactions with invested companies in the Mainland China

Details of significant transactions between the Group and Mainland China investees during the periods from January 1 to September 30, 2024 are provided in the “Information on Material Transactions” section.

(4) Information of Major Shareholders:

According to the information provided by Taiwan Depository & Clearing Corporation (TDCC), the Corporation has no shareholders holding more than 5% of the shares.

54

YUNGSHIN GLOBAL HOLDING CORPORATION Notes to Consolidated Financial Statements (Continued)

14. Segment Information

The Group considers the business from a geographic perspective, and divides reportable operating segments into the areas of business in Taiwan, USA, Mainland China and Japan. The Group derives its revenue primarily from the manufacturing and sale of pharmaceuticals and cosmetics.

Information and adjustments of the Group's operating departments are as follows:

Revenue:
Revenue from External
Customers
Reportable segment profit
or loss
Revenue:
Revenue from External
Customers
Reportable segment profit
or loss
Revenue:
Revenue from External
Customers
Reportable segment profit
or loss
Revenue:
Revenue from External
Customers
Reportable segment profit
or loss
July to September, 2024 July to September, 2024 July to September, 2024
Taiwan U.S.A. Mainland
China
Japan Adjustment and
Elimination
Total
$
1,656,318
168,601 18,146 260,708 - 2,103,773
$
245,524
31,766 (7,770) 72,815 - 342,335
Taiwan U.S.A. Mainland
China
Japan Adjustment and
Elimination
Total
$
1,397,353
114,349 21,870 186,845 - 1,720,417
$
190,957
(3,117) (1,058) 21,381 - 208,163
Taiwan U.S.A. Mainland
China
Japan Adjustment and
Elimination
Total
$
4,565,523
593,216 51,252 666,237 - 5,876,228
$
692,876
140,697 (15,349) 152,299 - 970,523
Taiwan U.S.A. Mainland
China
Japan Adjustment and
Elimination
Total
$
4,119,581
374,042 65,366 524,583 - 5,083,572
$
619,230
(19,627) (15,278) 62,722 - 647,047

The reconciliation of the Group's reportable operating segment profit or loss and the continuing operating segment's pre-tax income or loss is as follows:

Reportable segment profit or loss
Non-operating income and expenses
Profit or loss before income tax of
continuing operations
July to
September,
2024
July to
September,
2023
January to
September,
2024
January to
September,
2023
$ 342,335
27,937

208,163

137,337

970,523

277,892

647,047

224,398
$
370,272

345,500

1,248,415

871,445

Information on the measure of assets and liabilities of the Group is not for operational decision used, thus a disclosure is not required.

55